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Abstract

POST-TRANSCRIPTIONAL REGULATION OF THE DROSOPHILA ANTERIOR
DETERMINANT, BICOID
By John M. McLaughlin
Adviser: Diana P. Bratu

In a wide variety of biological contexts, messenger RNA (mRNA) is known to have a
complex and dynamic life cycle. In particular, the localization and translational control of
mRNA are essential for proper development in eukaryotes. The fly Drosophila melanogaster
is an excellent model for studying these processes. During D. melanogaster oogenesis, several
mRNAs are trafficked and localized within the developing egg chamber, and regulated at the
translational level to enable embryo patterning. One such mRNA, bicoid, is localized at the
anterior of the oocyte and translated in the early embryo, where its encoded protein directs
formation of the fly’s head and thoracic segments.
In this thesis, we investigated several aspects of bicoid ’s post-transcriptional regulation
that may impact its stability and translational timing. First, we demonstrate that bicoid
mRNA is present in Processing Bodies (P-bodies), cytoplasmic organelles implicated in
mRNA storage and decay. Perturbing P-body formation/structure, via manipulation of
the mRNA decay pathway, a↵ects the levels of bicoid and additional maternal transcripts.
We next explored the possibility that the microRNA (miRNA) pathway regulates the translational timing of bicoid. We find that in cell culture experiments, a bicoid reporter gene
is translationally repressed by miR-305; we also demonstrate that miR-305 is expressed in
ovaries. However, loss of miR-305 is not sufficient to alter ectopic bicoid mRNA translation
iv

in the egg chamber. To determine if any genes are singly required for bicoid translational
repression in the egg chamber, we used GFP-tagged transgenes to express bicoid mRNA in
vivo. Although we do not yet identity any candidate genes in this small screen, we show
that overexpression of bicoid mRNA results in its translation in the egg chamber, suggesting
that one or more factors normally act in its translational repression.
Overall, our work points to several plausible avenues of investigation into processes that
regulate the translational timing of bicoid mRNA during oogenesis. Moreover, our findings are also relevant to a general understanding of the complex, multifaceted problems
surrounding mRNA post-transcriptional regulation.
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Chapter 1
RNA post-transcriptional regulation

1.1

Background and Context

In the last several decades, the importance of post-transcriptional regulation of RNA has
become increasingly apparent. In a wide variety of organisms and biological contexts, the
regulation of RNA is essential for proper development. Messenger RNA (mRNA) in particular has been the focus of much of this research. An mRNA is subjected to processing
events during and immediately following its transcription, for example via RNA splicing and
regulated nuclear export. Once exported to the cytoplasm, an mRNA undergoes a variety
of other regulatory events throughout its life cycle, including transport and localization,
translational repression or activation, and decay. D. melanogaster oogenesis has been an instrumental paradigm for understanding the roles of localized and translationally controlled
mRNAs in development, and dissecting the mechanisms by which they are regulated.

1.2

Post-transcriptional regulation of messenger RNA

Following transcription and nuclear export, mRNAs form complex, higher-order particles
containing multiple proteins and RNA species (Fig 1.1). Some mRNAs, such as oskar mRNA
in D. melanogaster, can dimerize via base-pairing interactions within the 3’ untranslated region (3’UTR), forming large particles (Marchand et al, 2012). Trans-acting factors, such
as RNAs or proteins, are also capable of interacting with an mRNA. RNA-binding proteins
1

can include members of the exon junction complex (EJC), translational repressors and/or
activators, or other sequence-specific RNA-binding proteins. Additional trans-acting factors
may include translation initiation factors and adaptor proteins that couple the mRNA to
the microtubule (MT) or actin cytoskeletons.

Figure 1.1: Generic depiction of higher-order messenger ribonucleoprotein
(mRNP). The illustration depicts two mRNA molecules bound by RNA-binding proteins
and dimerizing via their 3’UTRs. Listed below are cis and trans-acting factors that can
mediate post-transcriptional regulation.
Through the assembly of mRNAs into particles, cells can exert finer temporal and spatial
control over the stability and translational efficacy of mRNA transcripts. This regulation is
especially important in the context of development. The morphology of certain cell types,
such as neurons, causes the sites of protein expression to be very distant from the cell nucleus,
making post-transcriptional gene regulation such as mRNA localization and translation control especially important. Cells which require a rapid response to environmental stimuli
will also rely more heavily on post-transcriptional regulation in order to quickly adjust their
translational profiles.
2

1.2.1

mRNA localization

Subcellular localization of mRNA transcripts confers several benefits. It aids the spatial
compartmentalization of gene products within the cell, a requirement for eukaryotic cells
which are relatively large and complex. It also allows for rapid changes in cellular gene
expression; the translation of an already localized transcript can occur more quickly than de
novo synthesis and transport of an mRNA. These processes are especially important in the
context of development. A large, morphologically complex tissue like the D. melanogaster
egg chamber relies heavily on the localization of mRNA. The developing fly embryo then
makes use of these maternally localized transcripts, and their protein products, to efficiently
pattern new tissues as cells divide and di↵erentiate.

One of the best characterized cases of mRNA localization is that of ASH1 mRNA in
the budding yeast S. cerevisiae. During budding, this mRNA is transported to the yeast
daughter cell, where it is translated and Ash1 protein localizes to the nucleus and acts as a
transcriptional repressor. The mother cell, which is depleted of Ash1 protein, can activate
expression of the HO endonuclease gene, which allows for mating type switching. Thus, the
localization of ASH1 mRNA in this system serves a critical functional role.

The localization of ASH1 mRNA depends on the actin cytoskeleton and actin-based motor proteins. Depolymerizing actin, by using drugs such as latrunculin-A, results in mislocalized ASH1 mRNA (Long et al, 1997). Proper localization of ASH1 mRNA is also dependent
on four ‘zipcode’ sequences present in both the open reading frame (ORF) and 3’UTR of the
transcript. Each sequence element is sufficient to localize a heterologous reporter transcript
to a budding daughter cell, however the presence of all four elements confers the most efficient localization (Chartrand et al, 2002). Proteins required for ASH1 mRNA transport and
localization include She1p, a type V myosin motor, as well as She2p and She3p, a zipcode
RNA-binding protein and adaptor protein, respectively (Bohl et al, 2000). The simple ge-
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netics of budding yeast helped researchers identify many additional factors that play a role
in ASH1 mRNA transport, localization, and anchoring at the bud tip (Gonsalvez et al, 2005).

Neurons — another important paradigm for mRNA localization — contain many mRNA
species that are localized in dendrites or axons, cellular processes which are relatively autonomous and distant from the nucleus. B-actin is another well studied mRNA that is
localized in a variety of systems including Xenopus laevis, chicken, mice, and humans. In
neurons, B-actin mRNA is localized to dendrites and its local translation plays a key role in
regulating synapse strength during processes such as learning and memory. Transport and
localization of B-actin mRNA requires both the MT and actin cytoskeletons (Condeelis et
al, 2005). A 54 nucleotide cis-element in the B-actin 3’UTR, termed the ‘zipcode’, is necessary and sufficient for proper localization of the mRNA (Chao et al, 2009). This sequence
is recognized by the protein ZBP1 (zipcode-binding protein 1), which functions in a protein
complex that localizes B-actin mRNA (Ross et al, 1997). Following its initial identification,
ZBP1 became the founding member of a family of RNA-binding proteins that regulate various mRNAs in di↵erent species (Yisraeli, 2005).

Many of the themes underlying ASH1 and B-actin mRNA localization recur in di↵erent
organisms and biological contexts. The presence of cis-acting sequences and/or secondary
structure motifs, often within an mRNA’s 3’UTR, is essential for linking an mRNA to specific RNA-binding proteins (RBPs). These RBPs in turn may couple a specific mRNA to
di↵erent microtubule or actin-based motor proteins. RBPs and cis-elements can also play
roles in assembling mRNAs into larger particles that aid in transport and/or translational
repression of the transcripts.

4

1.2.2

mRNA translational control

A subset of post-transcriptional regulation is dedicated to controlling where and when an
mRNA is translated into a protein within the cell. Translation of mRNA is understood in
terms of the ‘closed-loop’ model, according to which, circularization of the mRNA — by
bridging the 5’ and 3’ ends of the transcript — helps promote an efficient rate of translation
and recycling of ribosomes on the transcript. This closed-loop configuration is achieved by
several core eukaryotic translation initiation factors (eIFs), whose loading on the mRNA is
a prerequisite for translation initiation (Fig. 1.2).

In flies, the 5’ methyl-guanosine (m7 G) cap structure of an mRNA is first bound by
eukaryotic translation initiation factor E (eIF4E). A critical factor for circularization of the
mRNA and translation initiation is the large sca↵olding protein eIF4G. By binding eIFs
at the 5’ end of the mRNA (eIF4E and the DEAD-box RNA helicase eIF4A), as well as
poly-A binding protein (PABP) at the poly-A tail, eIF4G aids in the 5’ to 3’ looping of
the transcript. In addition, it also interacts with eIF3, an eIF which binds the 40S ribosomal subunit. Thus, eIF4G helps to both circularize the mRNA and to begin unwinding
and scanning of the 5’UTR by the 40S ribosomal subunit. The three critical eIFs — eIF4E,
eIF4A, and eIF4G — are collectively referred to as eIF4F once they are bound to the mRNA.

A great deal of translational regulation is thought to occur prior to the ‘initiation’ phase.
Because eIF4E is considered a limiting factor for translation initiation, translational repression can be achieved primarily by sequestration of eIF4E, or by preventing its binding to the
5’ cap or eIF4G. Illustrating this concept, there is a widely conserved family of eIF4E-binding
proteins (4E-BPs) in eukaryotes; in flies, eIF4E-transporter (4E-T) and Cup are two such
proteins. Through the use of a consensus amino acid motif shared among 4E-BPs, these
proteins can abolish or decrease rates of translation initiation by competing with eIF4G for
binding of eIF4E (Sonenberg and Hinnebusch, 2009).
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Figure 1.2: Simplified schematic of eukaryotic translation initiation factors
(eIFs). Depicted are the cap-binding protein eIF4E, the RNA helicase eIF4A, and scaffold protein eIF4G which bridges the complex to poly-A binding protein (PABP). This is
thought to circularize the mRNA and enhance the rate of translation initiation.

1.3

Transport and localization of an mRNA: the case of bicoid

bicoid (bcd ) mRNA is one of the well studied and classic patterning transcripts of the
D. melanogaster egg chamber. Because of the long history of studies (since 1988) on bcd,
the mechanism of its localization within the oocyte is fairly well characterized. The bcd
gene is the anterior patterning determinant of the D. melanogaster embryo; the mRNA is
synthesized in nurse cell nuclei, transported along the MT cytoskeleton into the oocyte, and
finally localized and anchored at the oocyte anterior cortex.

During early embryonic development, the previously localized bcd mRNA is then translated and Bcd protein di↵uses to form an anterior-posterior (AP) gradient within the embryo.
Bcd protein is a homeodomain transcription factor that activates the expression of several
gap genes in the embryo, the most notable being hunchback (hb). Bcd’s cascade of target
genes are responsible for patterning the head and thoracic structures of the embryo. In the
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absence of Bcd, embryonic head and thoracic structures do not form and posterior segments
are duplicated at the anterior.

Some of the early research on bcd mRNA transport focused on identifying regions within
the transcript which are required for its proper localization. A localization signal was eventually narrowed to a 625 base pair sequence within the bcd 3’UTR (Fig. 1.3), which is necessary
for proper bcd mRNA localization and is also sufficient to confer anterior localization on a
heterologous transcript (Macdonald and Struhl, 1988).

Figure 1.3: The structured 3’UTR of bicoid mRNA. Depicted is a simplified bcd
3’UTR, organized into five ‘domains’, with critical secondary structures and their functions
indicated. This diagram is adapted from a predicted RNA structure based on enzymatic
probing experiments (Brunel and Ehresmann, 2004).

7

There are two distinct and genetically separable phases of bcd mRNA transport during
oogenesis, the first being its transport from the nurse cell to oocyte compartment of the
egg chamber, and the second is bcd mRNA’s tight localization and anchoring at the oocyte
anterior cortex. Several trans-acting protein factors are required for these separate phases
of bcd mRNA transport and localization (Fig. 1.4). One of the early-acting protein factors
required for proper bcd mRNA localization is Exuperantia (Exu). A technically ingenious
study demonstrated that the formation of bcd mRNA/Exu particles in the nurse cell cytoplasm is required for bcd mRNA’s eventual anterior cortical localization (Cha et al, 2001).
A fluorescent, synthetic bcd mRNA directly injected into the oocyte cytoplasm localizes towards any cortical surface, but not specifically at the anterior. But injection of the synthetic
bcd mRNA first into the nurse cell cytoplasm, followed by removal and re-injection into the
ooplasm rescues anterior bcd mRNA localization. However, this rescue does not occur if the
first injection is performed on exu mutant egg chambers, demonstrating that Exu is critical
in forming nurse cell particles that are competent for transport.

The later phase of bcd mRNA transport and localization within the oocyte is mediated
by the RNA-binding protein Staufen (Stau). Staufen is known to bind di↵erent mRNA
species in the D. melanogaster egg chamber and embryo (Laver et al, 2013), although it was
initially identified as a maternal gene required for the correct localization of bcd mRNA. In
stau mutant females, bcd mRNA is not efficiently anchored at the oocyte anterior cortex,
resulting in a steeper Bcd gradient in the embryo and failure to activate Bcd target genes
(St Johnston et al, 1989). Drosophila Stau is one of the first proteins in which the doublestranded RNA binding domain (dsRBD) was identified and characterized (St Johnston et
al, 1992). Although Stau contains five dsRBDs, the third domain has been the most well
characterized biochemically. From mutagenesis analysis, it is known that this domain is
required for localization of both bcd and osk mRNAs (Ramos et al, 2000). A synthetic bcd
3’UTR injected into early D. melanogaster embryos can efficiently form particles with Stau
protein, and this process requires an intact MT cytoskeleton (Ferrandon et al, 1994).
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The association of bcd mRNA with Stau is mediated through secondary structure motifs
in the 3’UTR. The bcd 3’UTR contains several long stem-loops which are required for Stau
recognition (Ferrandon et al, 1997). In addition, intermolecular interactions between complementary loops are also necessary for efficient particle formation; bcd mRNAs that cannot
dimerize in vitro are also incapable of forming bcd mRNA/Stau particles in vivo (Wagner et
al, 2000).

Figure 1.4: bicoid mRNA localization in the egg chamber. Depicted are several
trans-acting protein factors responsible for localization of bcd mRNA in the nurse cell (Exuperantia: Exu; Swallow: Sww) or the oocyte (Staufen: Stau; Miranda: Mira) compartments
of the egg chamber. Also shown are MTs and the MT motors Kinesin and Dynein. Either
Miranda or an unknown adaptor protein is thought to link Staufen/bcd mRNA complexes
to the MT cytoskeleton.
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1.4

The microRNA pathway

MicroRNAs (miRNAs) constitute a class of endogenous, highly conserved, small regulatory
RNAs. They represent one of several classes of small silencing RNAs that are known to exist
in eukaryotes. They function as negative regulators of gene expression at the mRNA level,
either through the destruction or translational silencing of their target mRNA transcripts.

1.4.1

Discovery of microRNAs

The history of miRNA biology dates to the early 1990s, although the term itself would not
come into use until roughly ten years later. The first identified miRNA, C. elegans lin-4,
was reported in 1993 by two separate groups (Lee et al, 1993; Wightman et al, 1993). The
expression of the lin-4 gene is negatively correlated with protein levels of LIN-14; a decrease
in LIN-14 levels is critical for beginning the first larval stage. Interestingly, upon examining
the lin-4 and lin-14 sequences, researchers found that lin-4 encodes small RNAs of roughly
22 and 61 nucleotides, which bear antisense complementarity to a sequence within the lin-14
3’UTR. This was the first indication that lin-4 may mediate its negative regulatory e↵ects
via an antisense RNA-RNA interaction. In the following years, many additional C. elegans
miRNAs would be cloned, as well as miRNAs across a wide variety of eukaryotes.

1.4.2

Canonical biogenesis of microRNAs in D. melanogaster

MiRNAs are typically encoded by individual gene loci or in clusters which can potentially
generate several miRNAs. The canonical mode of miRNA biogenesis begins with transcription by RNA Polymerase II, to generate a primary miRNA (pri-miRNA) transcript
of several hundred nucleotides. In the nucleus, the RNase III enzyme Drosha, in complex
with the double-stranded RNA-binding domain (dsRBD) protein Pasha, cleaves the 5’ and
3’ single-stranded ends of the pri-miRNA to create a pre-miRNA stem-loop (Fig. 1.5).
Following its export to the cytoplasm, the pre-miRNA is further processed by a separate
RNAse III enzyme, Dicer-1 (Dcr-1). Dcr-1, cooperating with Loquacious, cleaves the loop
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end of the pre-miRNA, liberating a single-stranded RNA of 19-23 nt, the mature miRNA.
Its complementary stand, the miR*, is usually degraded although in some contexts may
be incorporated into an RNA-induced silencing complex (RISC) and participates in target
silencing. The mature miRNA exists in complex with an Argonaute (Ago) family protein;
in flies, Ago1 is dedicated to the miRNA pathway.

Figure 1.5: Simplified depiction of canonical microRNA biogenesis in
D. melanogaster. A miRNA gene is transcribed by RNA Pol II to produce the primary
miRNA (pri-miRNA) transcript. After processing by Drosha/Pasha, the pre-miRNA duplex
is exported to the cytoplasm. Another processing event by Dicer-1/Loquacious liberates the
mature miRNA strand, which is then loaded into Ago1 to form the microRISC.
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1.4.3

Alternative microRNA biogenesis pathways

In addition to the canonical mode of miRNA biogenesis, there exist several ‘alternative’
biogenesis pathways, several of which were first characterized in flies. The ‘mirtron’ pathway
processes miRNAs located in the introns of protein-coding genes. Instead of cleavage by
Drosha to form the pre-miRNA duplex, as in the canonical pathway, the pre-miRNA duplex
is liberated by the nuclear splicing machinery (Fig. 1.6). The pre-miRNA is then exported to
the cytoplasm and cleaved by Dicer-1. Interestingly, there is also the case of one vertebrate
miRNA, miR-451, which is matured in a Dicer-independent fashion (Cheloufi et al, 2010;
Yang et al, 2012). The pre-miRNA is not processed by Dicer cleavage but rather resected
by Ago2 to produce the mature miRNA. To date, vertebrate miR-451 is the only validated
case of Dicer-independent miRNA biogenesis.

Figure 1.6: Alternative miRNA biogenesis: the mirtron pathway. A mirtron is
liberated by the conventional splicing pathway to form a lariat structure. After debranching,
the pre-miRNA is exported to the cytoplasm and processed as a conventional miRNA.

1.4.4

Argonaute proteins and mechanisms of microRNA silencing

A wide range of eukaryotes are known to express miRNAs. In many of these organisms,
including Drosophila, miRNAs play major roles in various developmental processes, such
as tissue patterning, maintenance of cell identity, morphogenesis, metabolism, and immune
function. The explosion of miRNA research over the last decade has uncovered roles for
miRNAs in virtually every aspect of cellular and developmental biology.
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The core of miRNA activity resides in an Argonaute (Ago) family protein. Ago proteins
are evolutionarily widespread and ancient; they are found in animals, plants, fungi (S. cerevisiae being a notable exception), and some bacteria and archae. D. melanogaster contains
five Ago proteins, falling into two subfamilies: Ago1 and Ago2 in the Ago subfamily, and
Piwi, Ago3, and Aubergine (Aub) in the PIWI subfamily. An Ago protein contains three
characteristic domains: PAZ, MID, and PIWI. The PAZ (Piwi-Argonaute-Zwille) domain is
located at the protein’s N-terminus, and is responsible for anchoring the 3’ end of its bound
small RNA (Meister, 2013), while the MID (middle) domain anchors the 5’ end of the small
RNA. The PIWI domain contains a ‘catalytic triad’ (DDX) motif that bears the endonuclease slicer activity of the Ago protein. D. melanogaster Ago2 functions in the siRNA pathway
and therefore possesses a robust slicer activity for cleavage of perfectly complementary RNA
targets, while Ago1 possesses a weak slicer activity. A small RNA duplex is sorted on the
basis of its structural features into one of several RNA silencing pathways, and thus into different Ago proteins. An siRNA duplex of perfect complementarity is processed by Dicer-2,
which then aids in loading into Ago2, whereas a miRNA duplex of incomplete complementarity is processed by Dicer-1 and then loaded into Ago1.

In the vast majority of examined cases, miRNAs act as negative regulators of mRNA stability and/or translation. In plants, the Watson-Crick base pairing between a miRNA and
its target is perfectly complementary, in most cases resulting in target mRNA destruction.
In animals, the base pairing is partially complementary, with the most important miRNA
sequence region required for function being the ‘seed,’ nucleotides two through eight on the
mature miRNA. Disruption of seed binding in a canonical seed-matched target typically
abolishes the miRNA’s activity. In miRNA/target pairs lacking a perfect seed match, base
pairing with the 3’ end of the miRNA can compensate (Fig. 1.7).
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Figure 1.7: Basepairing of miRNA/target in plants and animals. Plant miRNAs are
often perfectly complementary to their target mRNA. In animals, miRNAs without perfect
seed matches can compensate with additional basepairing at their 3’ end.
The silencing activity of a miRNA/Ago1 complex is mediated via accessory protein factors that interact with Ago1 (Fig. 1.8). One such protein is GW182, which associates with
Ago1 via its N-terminal glycine-tryptophan (GW) repeats (Behm-Ansmant et al, 2006).
The GW182 C-terminus binds several other protein factors, including poly-A binding protein (PABP) and the Not1 subunit of the CCR4-Not deadenylase complex. Presumably,
recruitment of the CCR4-Not deadenylase complex to an mRNA target results in poly-A
tail shortening and either translational silencing or initiation of target RNA decay. Previous
studies suggest that GW proteins play a major role as e↵ectors of RNA silencing. Depletion
of GW182 results in derepression of miRNA targets, and directly tethering GW182 to an
mRNA reporter causes reporter silencing, even in the absence of an Ago protein (BehmAnsmant et al, 2006).

A complete mechanistic understanding of miRNA-mediated repression is still being pursued, and silencing mechanisms may vary substantially between organisms or cellular contexts. One active area of investigation is determining the relative contributions of pure trans14

Figure 1.8: MiRNA function in D. melanogaster. MiRNAs act as negative regulators
of mRNA stability and/or translation. In flies, miRNAs base pair with partial complementarity within the 3’UTR of a target mRNA. Ago1, in complex with the miRNA, can recruit
protein factors such as GW182, which help to mediate the downstream translational repression of the target mRNA.
lational repression versus target RNA decay in the operation of the miRNA pathway. With
respect to miRNA-mediated translational repression, it is thought to occur predominantly
at the initiation step of translation, by blocking the binding and/or activity of translation
initiation factors to the 5’ cap of the mRNA. Other recent studies suggest that the majority of mammalian miRNA activity is in destabilizing and/or degrading their target mRNAs
(Guo et al, 2010; Eichorn et al, 2014).

1.4.5

Identifying microRNA targets

One of the major goals of miRNA research programs is the identification of miRNA targets.
These investigations often begin in silico with computational target prediction tools. Algorithms for target prediction can take into account and weight several di↵erent variables,
including the evolutionary conservation of the target site or miRNA family, the free energy
of miRNA binding to its target, or the mRNA’s secondary structure. One commonly used
miRNA target prediction tool is TargetScan (www.targetscan.org), which has prediction options for human, mouse, fly, fish, and worms (Lewis et al, 2005; Kheradpour et al, 2007).
TargetScan incorporates into its predictions both evolutionary conservation of the target site
within the mRNA sequence, and the conservation of the miRNA family.
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Plant miRNA target prediction is simplified by the fact that these miRNAs possess
perfect base pair complementarity with their mRNA targets. In animals, the miRNA seed
region is often perfectly complementary to the target, but not in every case. Moreover, the
lack of perfect seed binding can be compensated by more extensive base pairing at the 3’
end of the miRNA. These nuances make reliable miRNA target prediction in animal species
more difficult. Target prediction in Drosophila is aided by the robust collection of genome
sequence data available; TargetScan Fly uses the sequenced genomes of 12 Drosophila species
in its miRNA target prediction.

1.4.6

MicroRNA annotation and community resources

When miRNA sequences began accumulating in significant quantities, the research community established databases for their recording and annotation in di↵erent model systems. The
most popular example, the online database ‘miRbase’, is a comprehensive collection of freely
available and downloadable miRNA sequences from a variety of species (Griffiths-Jones,
2004; Kozomara and Griffiths-Jones, 2014). In addition to the classic model systems such
as mouse, human, fly, Arabidopsis, and worm, the database collects, annotates, and assists
in naming miRNAs from many non-model species in a variety of biological taxa. For flies,
miRbase provides information on the pre-miRNA duplex and mature miRNA sequence, including references of its first cloning and experimental characterization, for example whether
its expression has been confirmed by Northern blotting and/or deep sequencing. To date,
there are 256 mature miRNA sequences reported for D. melanogaster, with 60% of them
considered ‘high confidence’ miRNAs (miRbase.org).

1.4.7

Genetic tools for studying microRNA function

The rapid advancement of miRNA research in D. melanogaster is owed in great part to
its advanced repertoire of genetic tools. The most useful tools have combined existing fly
technology — the Gal4/UAS system in particular — with transgenic techniques geared towards miRNA biology. Some notable tools among these include the miRNA sensor, miRNA
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sponge, and miRNA promoter reporter transgenes, as well as engineered miRNA deletion
alleles.

A miRNA sensor consists of a fluorescent transgene with binding sites for a specific
miRNA of interest within its 3’UTR (Fig. 5.16). This sensor can be expressed ubiquitously
or driven in specific tissues. When the sensor is co-expressed with its cognate miRNA, levels
of the fluorescent reporter are decreased. By combining the miRNA sensor with mutant
alleles for the miRNA of interest or miRNA pathway mutants, tissue-specific patterns of
miRNA activity can be uncovered (Dai and Lai, 2012).

The miRNA sponge utilizes a similar principle of operation, however — in contrast
to a sensor — its purpose is to sequester miRNA from its endogenous target (Loya et al,
2009). Therefore, a sponge typically contains more binding sites for its cognate miRNA than
a miRNA sensor (10-20 versus 2-3). Sponges can be used to mimic a miRNA hypomorph or
null allele in a tissue-specific fashion, by driving expression of the sponge with tissue-specific
Gal4 lines. This gives the researcher a greater degree of control than a traditional mutant
allele of a miRNA.

A miRNA promoter reporter can be used to report tissue-specific expression of a
specific miRNA. The known or predicted promoter of a miRNA is linked to a fluorescent
or histological tag (e.g. GFP or lacZ), allowing one to visualize tissues in which a miRNA
is endogenously expressed (Dai and Lai, 2012). This strategy has been used successfully in
flies and vertebrates, including mice.

Conditional miRNA expression is especially simple in flies, due to the well established Gal4/UAS technology. In order to uncover signaling pathways in which specific
miRNAs may participate, a Gal4-inducible miRNA transgene can be expressed ectopically
or at higher levels in particular tissues of interest (Bejarano et al, 2012).
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The use of miRNA deletions is increasing, due to the easy availability of gene targeting technology. One recent publication reported the systematic targeted deletion of 80
D. melanogaster miRNAs (Chen et al, 2014), which in combination with already existing
mutants cover over 99% of fly miRNAs.

1.4.8

Studies on microRNA function during D. melanogaster
oogenesis

D. melanogaster has been one of the main workhorses for elucidating the miRNA pathway and identifying functions for individual miRNAs in a variety of developmental contexts.
There has been relatively less work on miRNA function during oogenesis, but to date a number of informative publications exist on this system. Some of the earliest studies on oogenesis
demonstrated that Dicer-1 is required in germline stem cells for their self-renewal ability, suggesting that miRNA activity is essential for proper function of this cell type (Jin and Xie,
2007). Around the same time as these studies was the first systematic screen of miRNA
function during early embryonic development. In this study antisense oligonucleotides, targeting 46 di↵erent miRNAs, were injected into early embryos to assay the e↵ects of miRNA
knock-down on downstream development. Substantial patterning defects were observed for
roughly half of the knock-downs, indicating that various miRNAs play key roles in early
embryonic patterning and development (Leaman et al, 2005).

Several years later, the topic of miRNA function in germline cells of the egg chamber
was first addressed (Reich et al, 2009). GFP transgenes were engineered with or without
binding sites for miR-312, a miRNA previously demonstrated to be expressed at high levels
in 0-1 hour embryos, before the onset of zygotic transcription. This GFP reporter indicated
high levels of miR-312 activity in the nurse cells. Following this landmark paper, a number
of studies followed up by examining miRNA function in both germline cells and follicle cell
signaling pathways. For instance, an engineered knock-out of miR-184 helped demonstrate
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the necessity of this miRNA for dorsal-ventral patterning of the embryo (Iovino et al, 2009).
More recent work has taken advantage of an increasing number of targeted miRNA knockout lines. Border cell migration, an important event required for formation of the embryonic
micropyle, requires miR-989 (Kugler et al, 2013). And miR-318, which is highly expressed in
follicle cells, is required for dorsal-ventral axis specification and chorion formation; mutants
lacking miR-318 produce thin eggshells resulting in a reduced hatching rate (Ge et al, 2015).
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Chapter 2
Processing body function in the Drosophila egg
chamber

2.1

Background and Context

Processing bodies (P-bodies) are membrane-less cytoplasmic domains that exist in a wide
range of eukaryotes, and are known to be involved in the post-transcriptional regulation of
mRNA stability and translation. Over the last decade, research has uncovered homologous
P-body components in a variety of model organisms, from mammals to yeast. As basic
knowledge of P-body structure and function has grown, these organelles have also been
implicated in neurodegenerative disorders which stem from the aggregation of RNA/protein
complexes in the cytoplasm (Shukla and Parker, 2016).

2.2

Discovery and characterization of P-bodies

In 1997, the first mammalian cDNA encoding a 5’-3’ RNA exonuclease (Xrn1) was isolated
and its encoded protein characterized. In mouse cells, Xrn1 was distributed as discrete cytoplasmic particles throughout the cytoplasm (Bashkirov et al, 1997). Although unknown at
the time, this represented one of the first studies in the field of P-body research that would
unfold over the following two decades.
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The coining of the term ‘P-body’ dates to a 2003 Science article which characterized
components of the yeast mRNA decapping and 5’-3’ RNA decay pathways, and found them
to localize together in discrete cytoplasmic foci (Sheth and Parker, 2003). This study made
several observations which suggested that P-bodies are sites of RNA decay. P-bodies contain
mRNA decapping factors as well as mRNAs. They also respond to perturbations of mRNA
translation: when translation elongation was inhibited by trapping mRNA in polysomes,
P-bodies decreased in size, whereas inhibiting translation initiation caused P-bodies to increase in size. These dual observations suggest that P-bodies normally contain a pool of
translationally inactive/repressed mRNA (Sheth and Parker, 2003). Interestingly, components of the yeast RNA exosome did not localize to these structures, suggesting that they
are dedicated specifically to the 5’-3’ RNA decay pathway.

Since then, further support accumulated for the hypothesis that these structures represent sites of translationally repressed/inactive mRNA (Figure 2.1). First, P-body formation
requires the presence of RNA; inhibition of transcription or treatment of yeast cells with
RNase abolished the formation of P-bodies (Sheth and Parker, 2003). Additionally, translation initiation factors (with the exception of eIF4E) and ribosomal proteins are absent
from P-bodies (Brengues et al, 2005). More recent immuno-electron microscopy (immunoEM) experiments in the D. melanogaster egg chamber have reinforced the understanding
of P-bodies as electron-dense cytoplasmic regions from which ribosomes are excluded (Weil
et al, 2012). The list of protein factors that are associated with P-bodies has also grown
substantially (Table 3.1).
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2.3

Evolving terminology: P-bodies, GW-bodies, and sponge
bodies

Although ‘P-body’ is now the preferred term for describing these cytoplasmic domains, as
research in the field initially progressed, new terminology proliferated to refer to these structures in di↵erent organisms and tissues. As homologous protein components were identified
in di↵erent model systems, their large degree of functional overlap was revealed, and the
field eventually settled on the term ‘P-body’.

The term ‘sponge body’ was coined in a 1997 study on D. melanogaster egg chambers, in
reference to cytoplasmic, electron-dense, ‘sponge-like’ structures containing maternal mRNA
and protein (Wilsch-Brauninger et al, 1997). A follow-up study helped confirm the idea that
sponge bodies and P-bodies refer in large part to the same structures (Snee and Macdonald, 2009). Many of the protein factors described as sponge body markers, such as Me31B,
Dcp1/2, and eIF4E, had already been well characterized as central components of P-bodies
(Jain and Parker, 2013). Although no longer in common use, the term ‘sponge body’ has
persisted when referring to a subset of P-body like structures specific to germ cells (Kloc et
al, 2014).

‘GW-bodies’ have been studied since 2002, when a human autoimmune antigen was
identified in patients su↵ering from sensory neuropathy. Named ‘GW182’ for its molecular
weight and gylcine-tryptophan (GW) repeats, the protein localized in discrete cytoplasmic
speckles also containing mRNAs, which became known in the literature as ‘GW-bodies’
(Eystathioy et al, 2002). Subsequent studies identified GW182 orthologues in C. elegans,
D. melanogaster, and vertebrates species; interestingly, GW orthologues do not exist in
plants or fungi (Eulalio et al, 2009a). GW proteins are essential for miRNA-mediated gene
silencing, a fact that was first demonstrated in D. melanogaster cells (Rehwinkel et al, 2005).
As components of GW and P-body were identified and characterized, it was discovered that
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they have close compositional similarity and the term ‘P-body’ became the settled usage.
Although, one recent exception to this general usage rule is a study characterizing the degree
of overlap between P-body and GW-body components in the early D. melanogaster embryo
(Patel et al, 2016).

Figure 2.1: Simplified depiction of P-body function. P-bodies are membrane-less
cytoplasmic domains that harbor translationally repressed and/or decaying mRNA. It is
thought that a subset of mRNAs can traffic reversibly in and out of P-bodies, transitioning
from a translationally repressed to activated state.
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2.4

Conservation of P-body components in di↵erent model
systems

P-body research originated by identifying homologies between translational repressors in
Drosophila and decapping activators in budding yeast (Coller et al, 2001). It is fitting that
since this initial study, dozens of P-body associated proteins have been characterized in different model systems. The best characterized systems, D. melanogaster, C. elegans,
S. cerevisiae, and human cells, share many homologous factors that localize to P-bodies. A
unifying theme for P-bodies in di↵erent organisms has been the presence of proteins involved
in di↵erent aspects of RNA metabolism: mRNA decapping activators, translational repressors, and RNA exonucleases. However, there are a few notable di↵erences among organisms
with respect to P-body composition. In S. cerevisiae and mammals, the CCR4-Not deadenylase complex is associated with P-bodies, while it is notably absent in D. melanogaster.
And because GW182 and its homologues only exist in metazoans, this protein is not found
in yeast P-bodies.

2.5

Structure of P-bodies in the D. melanogaster egg chamber

In D. melanogater, P-bodies contain members of the mRNA decapping and 5’-3’ RNA decay
pathways, as well as some proteins that were originally identified as germline translational
repressors (Table 3.1). A core component of fruit fly P-bodies is ‘maternal expression at
31B’ (Me31B), a DEAD-Box RNA helicase first identified as a gene essential for oogenesis
(de Valoir et al, 1991). Roughly a decade later after its cloning, Me31B became implicated
in the translational regulation of several maternally expressed mRNA transcripts (Nakamura
et al, 2001). This study demonstrated that Me31B forms cytoplasmic particles with osk, bcd,
Bicaudal D (BicD), nanos (nos), oo18 RNA-binding protein (orb), polar granule component
(pgc), and germ cell-less (gcl ) mRNAs in the egg chamber. It also demonstrated a physical
interaction between Me31B and Exu, a protein already implicated in the localization of bcd
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mRNA; this interaction was RNAse-sensitive, suggesting that the proteins exist in a larger
RNA-rich complex in the cytoplasm.

Table 2.1: Protein factors associated with Drosophila P-bodies
Name
Me31B
Trailer Hitch (Tral)
Dcp1/2
Pacman
eIF4E
Edc3
GW182
Ge-1
Pat1
Staufen

Function
decapping activator/translational repressor
translational repressor
decapping proteins
5’-3’ exonuclease
translation initiation factor
decapping activator
miRNA function
decapping activator
decapping activator
mRNA localization

Fluorescence microscopy of egg chamber P-body components has demonstrated a morphology ranging from punctate foci to more sponge-like, reticulated structures which are
distributed throughout the cytoplasm of both nurse cell and oocyte compartments (Figure
2.2). More recently, immuno-EM has allowed for high resolution and fine-grained imaging
of P-bodies in the nurse cells and oocyte (Weil et al, 2012; Davidson et al, 2016). This
type of analysis has confirmed that ribosomes are excluded from P-bodies, and revealed that
maternal mRNAs exhibit di↵erential levels of association with the P-body ‘core’ and exterior
regions.
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Figure 2.2: P-body morphology in the D. melanogaster egg chamber.
(A) Fluorescence images of fly egg chambers, demonstrating mutual co-localization of Pbody components Me31B, Pacman, Dcp1, and Dcp2. Images adapted from Lin et al, 2008.
(B) Immuno-EM image of a cytoplasmic area within an oocyte, with electron-dense P-body
regions (outlined with broken blue line) excluding ribosomes (black particles).
Scale = 200 nm, image adapted from Weil et al, 2012.
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2.6

P-bodies, cellular stress, and stress granules

P-bodies are dynamic structures that respond to changing cellular conditions such as stress.
In D. melanogaster, stressors that can induce a P-body response include starvation/nutrient
deprivation, high temperature, and extended virginity (in females). When exposed to stress
conditions, P-bodies can drastically increase in size, transitioning from a punctate to a
more reticulated morphology. For example, flies exposed to protein-poor nutrient conditions
(without yeast paste) rapidly undergo a starvation response, one e↵ect of which is large cytoplasmic aggregates of P-bodies in the egg chamber. This response is mediated by insulin-like
peptide signaling via the follicle cells (Burn et al, 2014). Abrogation of the P-body response
drastically reduces survival rates in flies under starvation conditions, which suggests that
P-bodies perform essential functions for cell survivial, perhaps by storing non-translating
mRNA for later use (Burn et al, 2014).

Structures called ‘stress granules’ (SG) have been studied in parallel to P-bodies and display considerable overlap in their protein composition. For this reason, they are considered
a similar but distinct type of cytoplasmic mRNP granule. A main di↵erence between SGs
and P-bodies is the SG’s association with translation initiation factors, including eIF4G and
eIF4A (Table 3.2). SGs also lack members of the mRNA decapping complex, Dcp1 and Dcp2
(Decker and Parker, 2012). Therefore, SGs are thought to harbor translationally active
mRNAs, or mRNAs that must be rapidly shifted into active translation in response to cellular conditions.

Table 2.2: Protein factors uniquely associated with stress granules
Name
PABP
eIF3
eIF4G
eIF4A
40S ribosomal subunit

Function
poly-A tail
translation
translation
translation
translation
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binding protein
initiation factor
initiation factor
initiation factor

2.7

Links between P-bodies and small RNA silencing pathways

A number of studies have explored links between P-bodies and the miRNA and siRNA
pathways; in 2005, two separate publications were the first to report interactions between
P-bodies, GW182, and the miRNA/siRNA pathways in human cells. The first study demonstrated that Ago1 and Ago2 co-localize with the P-body component Dcp1 and physically
interact with both Dcp1 and Dcp2 (Liu et al, 2005a). Importantly, Ago2’s siRNA-binding
domain was required for its localization to P-bodies, suggesting that its function in siRNAmediated silencing is responsible for its P-body association. The link between miRNA/siRNA
activity and P-bodies was explored further through use of the MS2 RNA aptamer system
for live imaging of cellular mRNA. MS2-YFP reporter genes were engineered to contain artificial miRNA or siRNA binding sites. These reporter genes localized to P-bodies when
co-expressed with their cognate miRNA/siRNA, but failed to localize in the absence of their
targeting small RNA. Collectively, these data presented a first link between the activity of
small RNA-mediated gene silencing pathways and mRNA localization to
P-bodies.

In the second study, again using human cell lines, interactions between GW182, Ago
proteins, and P-bodies were examined (Liu et al, 2005b). The study described physical interactions between GW182 and both Ago1 and Ago2, and found that depletion of GW182
from cells reduced the silencing efficacy of miRNA or siRNA-targeted reporter genes. Furthermore, repression of the reporter genes required the Ago protein’s localization to P-bodies,
even when the reporter was directly tethered to an Ago protein. This study further reinforced the notion of P-bodies as sites of small RNA-mediated gene silencing.

Subsequent studies have demonstrated that even in the absence of microscopically detectable P-bodies, the miRNA pathway functions normally (Eulalio et al, 2007a). P-bodies
may be spatially correlated with small RNA activity but are not themselves required for
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small RNA-mediated silencing. However, global loss of miRNA function results in P-body
disassembly, suggesting that miRNA-targeted mRNAs may represent a large fraction of all
translationally repressed mRNPs in the cytoplasm (Eulalio et al, 2007b).

2.8

P-bodies and RNA decay

Degradation of mRNA is accomplished via specialized cellular pathways, with separate pathways dedicated to 5’-3’ or 3’-5’ decay. It is important to note that, in most examined cases,
P-bodies have been associated exclusively with the 5’-3’ decay pathway; components of the
3’-5’ decay pathway, such as the RNA exosome, do not localize to P-bodies. This highlights
the notion that RNA decay is highly regulated and compartmentalized within the cell.

A necessary precursor event for 5’-3’ decay is the removal of the mRNA poly-adenosine
(poly-A) tail (Fig. 2.3). Poly-A tail removal is performed mainly by the CCR4-Not complex,
a cytoplasmic multi-subunit protein complex. In flies, this complex contains two catalytic
subunits, Ccr4 and Pop2, which physically remove adenosine nucleotides from the 3’ end of
the tail. The Not1 protein is a sca↵olding subunit required for formation of the complex.
Once the poly-A tail is shortened below a critical threshold of 10-12 adenosines, poly-A
binding protein (PABP) can no longer bind the tail and the mRNA becomes susceptible to
removal of the 5’ methylguanosine (m7 G) cap structure. The Dcp1/2 proteins which perform this function are localized to P-bodies; Dcp2 harbors the enzymatic activity while Dcp1
functions as a decapping ‘co-activator’. Once decapping occurs, an mRNA rapidly becomes
a substrate for the 5’-3’ decay pathway. The enzyme Pacman (Drosophila homolog of Xrn1)
is the 5’-3’ exonuclease which performs this function.

A large body of evidence has established that P-bodies represent sites of RNA decay, in
addition to their roles in mRNA translational repression and storage. They contain members of the mRNA decapping and 5’-3’ decay pathway: Dcp1, Dcp2, and Pacman. P-bodies
also respond in both size and number to manipulations of the 5’-3’ RNA decay pathway.
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Preventing early precursor steps of RNA decay, by blocking CCR4 activity, causes P-bodies
to diminish in number. Conversely, blocking the decay process at a later stage, for example
via removal of Xrn1, increases the size and number of P-bodies. These findings indicate
that by decreasing or increasing the pool of deadenylated/non-translating mRNAs, P-bodies
respond by decreasing or increasing in size and number, respectively.

With respect to RNA decay and its relationship to P-bodies, studies on D. melanogaster
egg chambers have demonstrated similarities to those in yeast and other organisms. Fly
P-bodies respond to both alterations in mRNA translation rates and compromised RNA
decay activity. For example, in both dcp2 and pacman mutant egg chambers, with compromised decapping and 5’-3’ decay activities respectively, P-bodies increase in size, suggesting
that deadenylated mRNAs accumulate in P-bodies (Lin et al, 2008). Conversely, treatment
of egg chambers with cycloheximide, which traps actively translating mRNA in polysomes,
greatly reduces formation of P-bodies, as would be expected owing to a decreased cytoplasmic pool of non-translating RNA (Lin et al, 2008).
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Figure 2.3: Deadenylation followed by RNA decay in P-bodies. An mRNA is first
deadenylated in the cytoplasm by the CCR4-Not complex, followed by recruitment into a
P-body (broken line). The 5’-3’ decay of mRNA is one activity that can occur in P-bodies.
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Chapter 3
bicoid mRNA association with P-bodies

3.1

Introduction

P-body function in the Drosophila egg chamber has been examined in a limited number of
studies (Lin et al, 2008). However, previous work has demonstrated that several maternally
localized transcripts, including oskar, bicoid, and gurken, each display some degree of localization to P-bodies. Building on preliminary studies which were spatially restricted to the
anterior of the oocyte, we began by examining the degree of bcd localization to P-bodies
throughout oogenesis.

3.2

Presence of bicoid mRNA in nurse cell and oocyte P-bodies

Previous work on bcd mRNA’s association with P-bodies was restricted to the oocyte anterior. We examined bcd ’s presence in P-bodies at varying stages of oogenesis, in both
nurse cell and oocyte compartments of the egg chamber. To visualize P-bodies in the egg
chamber, we made use of GFP and YFP protein-trapped fly lines, labeling the Drosophila
P-body components Me31B (YFP label) and Trailer Hitch (Tral) (GFP label). Each proteintrapped line displays a punctate fluorescent signal consistent with P-body morphology observed by antibody staining (Lin et al, 2008). We performed single molecule fluorescence in
situ hybridization (smFISH) using bcd -specific Stellaris probes, and imaged bcd mRNA in
the Me31B-YFP and Tral-GFP egg chambers, respectively. Using a spinning disc confocal
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microscope, we observed extensive co-localization during early and mid-late oogenesis, in
both the nurse cell and oocyte compartments of the egg chambers (Fig. 3.1).

Figure 3.1: bcd mRNA associates with P-bodies at di↵erent developmental
stages. (A) Early and (B) mid-to-late stage Me31B-YFP and Tral-GFP (green) egg chambers were used for smFISH for bcd mRNA (red). The merge (yellow) panels define areas
where bcd mRNA co-localizes with P-body components. Images are composites of 3-4 optical
Z slices (Z step of 0.5 µm). Scale bar = 25 µm, with 40X magnification. Representative
images from at least three independent experiments.

33

At higher magnification, the co-localization of bcd mRNA with Me31B-YFP is more apparent in the egg chamber’s nurse cells, as well as P-body morphology which varies from
punctate foci to more reticulated structures (Fig. 3.2).

Figure 3.2: bcd mRNA associates with P-bodies in the nurse cells. (A) Stage 6
and (B) stage 8 egg chambers expressing Me31B-YFP (green) and used for smFISH for bcd
mRNA (red). The merge (yellow) panels define areas where bcd mRNA co-localizes with
P-body components. Images are composites of 3-4 optical Z slices (Z step of 0.5 µm). Scale
bar = 25 µm, with 63X magnification. Representative images from at least three independent
experiments.

3.3

Function of the CCR4-Not deadenylase complex and 5’-3’
RNA decay pathway

One of the precursor events necessary for sequestration of mRNAs into P-bodies is the shortening of the 3’ poly-adenosine (poly-A) tail. In flies, this function is performed mainly by
the CCR4-Not deadenylase complex, a multi-subunit protein complex (Fig. 3.3). Of the
several members of the full complex, we examined the two catalytic protein subunits which
degrade the poly-A tail, Ccr4 and Pop2, and the sca↵olding subunit, Not1, which is required
for efficient formation of the complex.
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Figure 3.3: Schematic of the CCR4-Not complex. Pop2 and Ccr4 are the catalytic
subunits bearing deadenylase activity. Not1 serves as a sca↵old for the entire complex.
It is thought that following entry into a P-body, an mRNA is capable of becoming a
substrate for the 5’-3’ RNA decay pathway. Following removal of the 5’ methylguanosine
(m7 G) cap by the Dcp1/2 proteins, the mRNA is decayed from the 5’ end by the 5’-3’
exonuclease, Pacman (Fig. 3.4). With the goal of modulating P-body size and observing
downstream e↵ects on maternal mRNA levels, we used transgenic RNAi fly lines (TRiP) to
deplete di↵erent components of the CCR4-Not complex and 5’-3’ decay pathway. We used
TRiP lines targeting pacman, ccr4, not1, and pop2 (Table 3.1). Our experimental setup was
as follows: for each knock-down, changes in P-body morphology were observed by visualizing
Me31B-YFP and Tral-GFP, respectively. In parallel, ovarian total RNA was isolated from
each knock-down and used for qPCR to measure the levels of three maternally localized
transcripts, bcd, osk, nos, as well as three ‘reference’ genes, rp49, cdk9, and HetA (Table
3.2). The use of HetA, a germline-specific transposable element, as a reference gene allowed
35

us to control for decreased germline volume as a side e↵ect of the knock-down.

Figure 3.4: Schematic of mRNA decapping and 5’-3’ decay. Following 5’ decapping
by Dcp1/2, an mRNA can serve as a substrate for the 5’-3’ exonuclease Pacman.
Table 3.1: Members of the Drosophila CCR4-Not deadenylase and 5’-3’ mRNA
decay pathways
Gene name
pacman
not1
ccr4
pop2

3.4

Function
5’-3’ exonuclease
sca↵olding subunit
3’-5’ exonuclease subunit
3’-5’ exonuclease subunit

E↵ect of pacman knock-down on P-body size

In pacman KD egg chambers, P-bodies increased in size and intensity (Me31B-YFP and
Tral-GFP signal) (Fig. 3.5, A), consistent with previous observations in pacman mutant
egg chambers (Lin et al, 2008). However, there was not a substantial change in maternal
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Table 3.2: mRNAs measured by qPCR
mRNA
bicoid
oskar
nanos
rp49
cdk9
HetA

Expression
germline
germline
germline
germline & somatic
germline & somatic
germline

Class
target gene
target gene
target gene
reference gene
reference gene
reference gene

transcript levels between the control (mCherry) and pacman knock-downs (Fig. 3.5, B).

3.5

E↵ect of not1 knock-down on P-body morphology

In knock-downs of not1, the sca↵olding subunit, P-body morphology was drastically changed,
from the typical punctate to a more di↵use morphology (Fig. 3.6, A). There was also a substantial decrease in bcd, nos, and to a lesser extent osk mRNA levels when compared to the
control knock-down (Fig. 3.6, B).

3.6

E↵ects of ccr4 and pop2 knock-downs on P-body morphology

We next examined knock-downs of ccr4 and pop2, both exonuclease subunits of the deadenylase complex. The ccr4 knock-downs did not display a substantial change in P-body
morphology (Fig. 3.7, A) or maternal transcript levels (Fig. 3.7, B). However, similar to
not1, knock-down of pop2 resulted in a di↵use P-body morphology (Fig. 3.8, A) and the
levels of maternal mRNAs were significantly decreased (Fig. 3.8, B).
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Figure 3.5: pacman KD increases P-body size. (A) Control (mCherry) and pacman
knock-downs in Me31B-YFP and Tral-GFP (green) egg chambers, respectively. Images are
composites of 3-4 optical Z slices (Z step of 0.5 µm). Scale bar = 25 µm, with 63X
magnification. Representative images from at least three independent experiments.
(B) qPCR quantification of mRNA levels. The colored legend indicates the ccr4 and control
(mCherry) knock-downs. The x-axis indicates the mRNA being quantified. The y-axis indicates the relative mRNA level as a percentage of the control knock-down. N = 9 (combined
three technical replicates from three independent experiments. Error bars = SD (in some
samples, error bars are concealed by the colored box).
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Figure 3.6: not1 KD causes di↵use P-body distribution. (A) Control (mCherry)
and not1 knock-downs in Me31B-YFP and Tral-GFP (green) egg chambers, respectively.
Images are composites of 3-4 optical Z slices (Z step of 0.5 µm). Scale bar = 25 µm, with
63X magnification. Representative images from at least three independent experiments.
(B) qPCR quantification of mRNA levels. The colored legend indicates the ccr4 and control
(mCherry) knock-downs. The x-axis indicates the mRNA being quantified. The y-axis
indicates the relative mRNA level as a percentage of the control knock-down. N = 9 (combined three technical replicates from three independent experiments. Error bars = SD (in
some samples, error bars are concealed by the colored box).
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Figure 3.7: ccr4 KD alters P-body distribution. (A) Control (mCherry) and ccr4
knock-downs in Me31B-YFP and Tral-GFP (green) egg chambers, respectively. Images are
composites of 3-4 optical Z slices (Z step of 0.5 µm). Scale bar = 25 µm, with 63X
magnification. Representative images from at least three independent experiments.
(B) qPCR quantification of mRNA levels. The colored legend indicates the ccr4 and control
(mCherry) knock-downs. The x-axis indicates the mRNA being quantified. The y-axis indicates the relative mRNA level as a percentage of the control knock-down. N = 9 (combined
three technical replicates from three independent experiments. Error bars = SD (in some
samples, error bars are concealed by the colored box).
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Figure 3.8: pop2 KD causes di↵use P-body distribution. (A) Control (mCherry)
and pop2 knock-downs in Me31B-YFP and Tral-GFP (green) egg chambers, respectively.
Images are composites of 3-4 optical Z slices (Z step of 0.5 µm). Scale bar = 25 µm, with
63X magnification. Representative images from at least three independent experiments.
(B) qPCR quantification of mRNA levels. The colored legend indicates the ccr4 and control
(mCherry) knock-downs. The x-axis indicates the mRNA being quantified. The y-axis
indicates the relative mRNA level as a percentage of the control knock-down. N = 9 (combined three technical replicates from three independent experiments. Error bars = SD (in
some samples, error bars are concealed by the colored box).
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3.7

Synopsis and Discussion

In this chapter, we report that bcd mRNA co-localizes with two P-body markers, Me31B
and Tral, at di↵erent stages of oogenesis, in both the nurse cell and oocyte compartments
of the egg chamber. We examined the distribution of egg chamber P-bodies using RNAi
lines targeting di↵erent members of the CCR4-Not deadenylase complex. Depleting not1
and pop2, and presumably reducing cytoplasmic deadenylase activity, resulted in a dramatic
change in P-body distribution, from a punctate to a more di↵use cytoplasmic morphology.

Both Ccr4 and Pop2 are catalytic subunits of the deadenylase machinery, yet the ccr4
knock-down did not produce the same dramatic phenotype of pop2 KD. One possible explanation for this finding is tissue-specific activities of Ccr4 and Pop2. Previous work has
shown that in Drosophila S2 cells, the activity of one subunit predominates. Similarly, it
is possible that in the ovary the activity of Pop2 is more essential for deadenylase function,
with Ccr4 playing a minor role.

Overall, our findings seem to suggest that cytoplasmic P-bodies act to stabilize maternal
transcripts, which appears to contradict the notion that RNA decay is one of their major
activities. Under normal cellular conditions, it is unlikely that RNA decay plays a major
role in the regulation of the maternal patterning transcripts in the egg chamber. The fact
that mature Drosophila eggs - which no longer perform transcription - are still capable of
being fertilized for over one week after maturation suggests that the localized transcripts are
highly stable in vivo.

One interesting observation from previous work on oocyte P-bodies is that shortly following egg activation, bcd mRNA dissociates from Me31B foci in the egg. During this
developmental time period, bcd mRNA translation is initiated. This correlation might suggest that bcd ’s removal from P-bodies is required for its translation, although a causal link
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has not been established. The authors of this study observed Me31B foci disassembly following egg activation, suggesting that egg activation has a more global e↵ect on P-body
morphology, which is perhaps linked to the global changes in protein translation that are
known to accompany egg activation.

An obvious question raised by our findings, as well as by previous work, is the mechanism
by which bcd mRNA is localized to P-bodies in the first place. To our knowledge, there has
not been an exhaustive description of cellular mRNAs regarding their localization to Pbodies, similar to the large-scale screen for localized embryonic mRNAs performed by the
Krause lab, University of Toronto. Therefore, the field currently lacks an estimate of the
fraction of cellular mRNAs which are sequestered in P-bodies. However, super-resolution
fluorescence imaging as well as electron microscopy have definitively shown that maternal
transcripts di↵er in the degree of their compartmentalization within P-bodies (Weil et al,
2012), suggesting that this process must be regulated at some level. The mechanism by
which this compartmentalization is controlled is also unknown.
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Chapter 4
MiR-305 expression and predicted targeting of bicoid
mRNA

4.1

Introduction

In model systems such as yeast and mammalian cell culture, P-bodies have been implicated
in the activity of small regulatory RNA pathways, such as the siRNA and miRNA pathways
(Liu et al, 2005). Both the 5’ and 3’ untranslated regions (UTR) of an mRNA can serve
important roles with respect to translational regulation. A collection of previous work on bcd
mRNA suggests that the 3’UTR may be the main mediator of its translational repression.
First, replacing the osk 3’UTR with that of bcd causes it to adopt bcd ’s translational timing.
Second, it has been shown that the bcd 5’UTR is not required for its translational repression
during oogenesis, suggesting that the 3’UTR region may be more important for this function
(Driever et al, 1990). A survey of the literature led us to hypothesize that bcd ’s presence
in egg chamber P-bodies may be indicative of regulation by one or more miRNAs. With
the importance of bcd ’s 3’UTR in mind, we explored this possibility by using computational
methods to identify possible miRNA binding sites in the bcd transcript.
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4.2

Computational microRNA target prediction

Investigations into miRNA targeting of an mRNA typically begin with a computational prediction of candidate miRNAs. Various softwares are now available for this purpose, which
vary in their prediction methods. Some algorithms place an emphasis on evolutionary conservation of the miRNA site within the target, while others use mRNA secondary structure
to predict single-stranded regions that would be amenable to miRNA binding. We used the
free online miRNA prediction software TargetScan (http://www.targetscan.org) to query the
bcd 3’UTR. TargetScan uses the evolutionary conservation of the miRNA binding site and
conservation of the miRNA family as criteria for identifying likely target sites. An alignment of the bcd 3’UTR sequence from twelve Drosophila species identified a single highly
conserved, predicted binding site for miR-305 (Fig. 4.1).

Figure 4.1: Partial sequence alignment of bcd 3’UTR containing predicted
miR-305 site. The predicted seed-binding region in the bcd 3’UTR is highlighted in red.
The top of the alignment indicates the nucleotide number following the stop codon.

4.3

Design of bicoid 3’UTR reporter assay

Reporter gene assays are often used to test the repressive e↵ects of a miRNA on a putative
mRNA target. To examine the capacity for miR-305 to repress translation via the
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bcd 3’UTR, we used the pSiCheck reporter gene assay (Promega) in Drosophila S2 cells (Fig.
4.2). The full bcd 3’UTR was cloned downstream of the Renilla luciferase coding sequence.
On the same vector, a firefly luciferase transgene served as an internal control for transfection efficiency. S2 cells were then co-transfected with the Luciferase-bcd 3’UTR vector
and a DsRed-miRNA or empty DsRed plasmid. The assay’s ability to robustly measure
target-specific miRNA-mediated silencing was demonstrated by co-expression of mirtron-2
and its “perfect target” transgene. Mirtron-2 strongly repressed its target reporter but had
no e↵ect on the bcd 3’UTR reporter, as expected (Fig. 4.3).

Figure 4.2: MiRNA Reporter Assay: Principle of Operation. Assay components:
(1) Renilla Luciferase reporter containing the 3’UTR of interest. (2) A DsRed fluorescent
reporter encoding a pri-miRNA of interest in its 3’UTR. The two vectors are co-transfected
into Drosophila S2 cells, followed by luminescence measurements.

Figure 4.3: Proof of principle: mirtron-2 repression of a perfect target. For each
floating box, the pSiCheck vector is indicated in the color-coded legend. The co-transfected
DsRed vector is indicated on the x-axis. Relative luciferase (Renilla/Firefly) is indicated
on the y-axis. N = 8 (combined four technical replicates from each of two independent
experiments). Error bars = SD.
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4.4

The bicoid 3’UTR contains a Nanos Response Element

The bcd 3’UTR contains a motif known as the Nanos Response Element (NRE), a bipartite
motif which has been previously implicated in regulating bcd mRNA stability during early
embryogenesis (Gamberi et al, 2002). A homologous NRE found in the hunchback (hb)
3’UTR serves as a binding site for the translational repressor Pumilio, and there is evidence
that Pumilio can also bind the bcd NRE (Gamberi et al, 2002). The bcd NRE consists of one
“Box A” and two “Box B” motifs, and partially overlaps with the predicted miR-305 binding
site (Fig. 4.4). Interestingly, several lines of evidence, drawn from studies published in the
last few years, suggest a role for Pumilio as an accessory component of the miRNA machinery in di↵erent cellular contexts. First, sequence analysis of mRNAs has demonstrated that
Pumilio binding sites are significantly enriched in the vicinity of high-confidence miRNA
binding sites (Galgano et al, 2008). In human cells, Pumilio binding has been shown to
enhance miRNA recognition of di↵erent target mRNAs (Kedde et al, 2010; Miles et al,
2012). Second, the C. elegans Pumilio homolog, FBF, as well as mammalian PUM-2, physically associate with Ago1 and eEF1A to attenuate translation elongation (Friend et al, 2012).

Figure 4.4: Organization of the hunchback and bicoid Nanos Response Elements.
The hb 3’UTR contains two full NREs, while bcd contains “1.5” NREs comprised of one Box
A and two Box B motifs.
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To determine whether an intact NRE is required for repression by miR-305, we employed
a mutagenesis scheme which allows for the separation of miR-305 and NRE-mediated repression on bcd (Fig. 4.5). The dinucleotide mutations introduced into each Box have been
previously demonstrated to abolish Pumilio binding to the hb NRE (Wharton and Struhl,
1991).

Figure 4.5: Mutagenesis of bicoid Nanos Response Element. Mutations indicated
in purple above WT Box A (red) and Box B (blue) sequences. MiR-305 seed region is boxed.

Table 4.1: NRE Box sequences and mutations
NRE Box
Box A
Box B1
Box B2

4.5

WT sequence
guugu
auugua
auugua

Mutated sequence
caugu
auacua
auacua

The upstream and downstream NRE Boxes are not required
for repression by miR-305

We performed reporter assays to test miR-305’s ability to repress the bcd 3’UTR in the
context of each dinucleotide mutation, both singly and in combination. The miR-305 seed
binding region was also separately mutated such that the altered nucleotides do not overlap
with any NRE Box sequence. Mutation of the miR-305 seed binding region abolished
miR-305’s ability to repress, as expected (Fig. 4.6). We then tested the necessity for miR305 repression of the upstream Box A and Box B2, which falls downstream of the miR-305
binding site. Mutation of either sequence alone had no e↵ect on miR-305’s ability to repress
translation of the target (Figs. 4.7 - 4.8).
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Figure 4.6: Seed region mutation abolishes repression by miR-305. For each
floating box, the pSiCheck vector is indicated in the color-coded legend. The co-transfected
DsRed vector is indicated on the x-axis. Relative luciferase (Renilla/Firefly) is indicated on
the y-axis. *** = p<0.001; ns = not significant. N = 12 (combined four technical replicates
from each of three independent experiments). Error bars = SD.

Figure 4.7: NRE Box A is not required for miR-305 mediated repression. For each
floating box, the pSiCheck vector is indicated in the color-coded legend. The co-transfected
DsRed vector is indicated on the x-axis. Relative luciferase (Renilla/Firefly) is indicated on
the y-axis. **** = p<0.0001; *** = p<0.001; ns = not significant. N = 12 (combined four
technical replicates from each of three independent experiments). Error bars = SD.
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Figure 4.8: NRE Box B2 is not required for miR-305 mediated repression.
For each floating box, the pSiCheck vector is indicated in the color-coded legend. The
co-transfected DsRed vector is indicated on the x-axis. Relative luciferase (Renilla/Firefly)
is indicated on the y-axis. **** = p<0.0001; *** = p<0.001; ns = not significant. N = 12
(combined four technical replicates from each of three independent experiments).
Error bars = SD.

4.6

The bicoid NRE Box B1 directly overlaps with the miR-305
binding site

The Box B1 sequence in the bcd NRE directly overlaps with the predicted binding region for
miR-305 (Fig. 4.5). To determine if miR-305 can repress in the context of a mutated Box
B1, we introduced compensatory mutations into the pre-miR-305 hairpin (the compensatory
mutant hairpin is termed miR-305*) such that miR-305* can bind, with an identical level
of complementarity, to the mutant NRE sequence (Fig. 4.9). MiR-305* was able to repress
both the bcd NRE Box B1 mutant reporter (Fig. 4.10), and a reporter bearing combined
mutations in all three NRE Boxes (Fig. 4.11). Collectively, these observations demonstrate
that an intact NRE sequence is not required for miR-305 mediated repression.
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Figure 4.9: Schematic of pre-miR-305 compensatory mutations. The pre-miR-305
hairpin (top) with the mature miR (boxed) and miR* sequences indicated in green. The
compensatory mutant pre-miR-305 hairpin (bottom) with mutated nucleotides indicated in
red.

Figure 4.10: NRE Box B1 is not required for miR-305 mediated repression.
For each floating box, the pSiCheck vector is indicated in the color-coded legend. The cotransfected DsRed vector is indicated on the x-axis. Relative luciferase (Renilla/Firefly) is
indicated on the y-axis. **** = p<0.0001; *** = p<0.001; ns = not significant. N = 12
(combined four technical replicates from each of three independent experiments).
Error bars = SD.
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Figure 4.11: NRE boxes are not required for miR-305 mediated repression.
For each floating box, the pSiCheck vector is indicated in the color-coded legend. The cotransfected DsRed vector is indicated on the x-axis. Relative luciferase (Renilla/Firefly) is
indicated on the y-axis. **** = p<0.0001; *** = p<0.001; ns = not significant. N = 12
(combined four technical replicates from each of three independent experiments).
Error bars = SD.

4.7

Detection of ovarian miR-305 expression by qPCR

To determine if miR-305 is expressed in fly ovaries, consistent with a role in regulation
of bcd translation, we used a modified qPCR assay for the detection of specific mature
miRNAs. The assay makes use of stem-loop forming reverse-transcription (RT) primers,
whose secondary structure increases the affinity of the primer for the 3’ end of its specific
mature miRNA (Fig. 4.12). Abundant levels of miR-305 were detected in ovarian small
RNA lysate, along with several other miRNAs, while miR-280 served as a negative control
(Fig. 4.13). In the time since these experiments were performed, several published studies
have corroborated the maternal expression of miR-305 using RNA sequencing (Marco, 2015).
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Figure 4.12: Stem-loop qPCR assay for detecting mature miRNAs. A stem-loop
forming DNA primer, whose 3’ end is specific for a single mature miRNA, is added to a small
RNA lysate. An RT reaction produces a cDNA, followed by a conventional qPCR reaction
to quantify levels of the miRNA.

Figure 4.13: Quantitation of ovarian miR-305 levels.The raw qPCR amplification
curves for miR-305 and other miRNAs (left). These curves were converted to histograms
(right) based on absolute quantitation methods, and presented as log(copy number) per
250 ng of small RNA lysate.
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4.8

Organization of the miR-305 locus and mutant
alleles

The miR-305 gene is located on the left arm of chromosome 2, clustered with miR-275 and
the non-coding RNA CR43857 (Fig. 4.14). We obtained a targeted knock-out of
miR-275/305 (Stephen Cohen laboratory, Institute of Molecular and Cell Biology, Singapore), as well as the cuc1 allele of CR43857(Bloomington Drosophila Stock Center), which
abolishes its transcription (Table 4.2).

Figure 4.14: Organization of the miR-305 gene locus. MiRs 275 and 305 are clustered
and transcribed from the non-coding RNA CR43857.

Table 4.2: Alleles located in the miR-275/305 cluster
Allele
miR-275/305 KO
cuc1
Df(2L) BSC189

Description
Targeted deletion of miR-275/305 cluster
Abolishes transcription of CR43857
Deletion spanning the CR43857 and miR-275/305 loci
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To validate the miR-305 KO, these alleles were crossed in several combinations, followed
by total ovarian RNA isolation and qPCR to detect levels of the miR-305 primary transcript.
The miR-305 homozygous KO, as well as each allele in trans to a deficiency spanning the
entire miR-275/305 locus (Df(2L) BSC189 ), reduced miR-305 expression to undetectable
levels (Fig. 4.15).

Figure 4.15: Validation of miR-305 KO alleles. The miR-275/305 KO, cuc1 , and
Df(2L) alleles were combined, ovarian RNA isolated, and pri-miR-305 levels measured by
qPCR. Histogram represents combined samples from two independent experiments.
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4.9

MiR-305 GFP sensor reports activity in the egg chamber

We used a miRNA sensor fly line (gift from Stephen Cohen’s lab) to determine if miR-305 is
active in the germline cells of the egg chamber. The sensor contains a ubiquitously expressed
GFP transgene tagged with an NLS, and two miR-305 binding sites in its 3’UTR (Fig. 4.16).
The sensor line was crossed into the mutant alleles described above. Partial de-repression of
the sensor was observed in each mutant background, compared to the WT (Fig. 4.17).

Figure 4.16: MiR-305 sensor: Principle of operation. It consists of a GFP transgene,
driven by the Ubiquitin promoter, tagged with a nuclear localization sequence (NLS), and
two optimal binding sites for miR-305 in its 3’UTR.

Figure 4.17: MiRNA sensor reports miR-305 activity in the egg chamber. The
miR-305 GFP sensor was crossed into WT, miR-275/305 KO, Df(2L), and cuc1 backgrounds.
De-repression of the sensor was observed in the nurse cells in comparison to the WT
background. Image represents single optical Z slice. Scale = 25 µm, with 63X magnification.
Representative images from three independent experiments.
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4.10

Synopsis and Discussion

In this chapter, we demonstrated that the bcd 3’UTR contains a predicted target site for
miR-305, and that miR-305 is expressed and active in ovaries. miR-305 is able to repress a
bcd 3’UTR reporter gene in an S2 cell assay system. This repressive activity does not require
an intact Nanos Response Element in the bcd 3’UTR.

While the bcd 3’UTR reporter experiments were performed in a cell culture model, they
may be suggestive of miRNA regulation taking place in vivo. Repression of the bcd reporter
was specific and dependent on both miR-305 and the seed binding region within the 3’UTR.
Collectively, these data suggest that miR-305 is at least capable of regulating the bcd 3’UTR
and is expressed and active during the appropriate developmental time period to do so.

Previous work has suggested possible interactions between Pumilio and the miRNA pathway, for instance that Pumilio binding is required to change the local secondary structure of
an mRNA in order to allow for miRNA access. We explored a similar possibility in the bcd
3’UTR reporter assay by mutating NRE sequence motifs separately and in combination, to
determine whether these motifs must be intact in order for miR-305 to repress the reporter.
While Pumilio is expressed at high levels in S2 cells, Nanos protein is not present (Weidmann and Goldstrohm, 2012). It is possible that Nanos is required to mediate the repressive
e↵ects of Pumilio in S2 cells, although Pumilio has been shown to be capable of binding the
NRE and repressing translation independently of Nanos (Weidmann and Goldstrohm, 2012).
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Chapter 5
Design and expression of bicoid transgenes

5.1

Introduction

In order to study the timing of bcd translation in vivo, we constructed GFP-tagged bcd
transgenes for expression during oogenesis. These transgenic fly lines were then manipulated
using RNAi or mutant alleles to investigate the genetic requirements for bcd translational
repression in the egg chamber.

5.2

Design of gfp-bcd transgene for in vivo expression

In order to recapitulate bcd ’s native expression levels as closely as possible, we constructed
a GFP-tagged transgene bearing the endogenous bcd promoter, coding sequence, introns,
5’ and 3’ regulatory elements (Fig. 5.1). Using the

C31 site-specific integration system,

the transgene was inserted into the X chromosome. The gfp-bcd fly line is viable as a homozygous insertion. To confirm correct expression of the transgenic bcd, early stage embryos
were visualized for GFP expression. We observed the expected anterior gradient of GFP-Bcd,
indicating that the localization and translational regulation of bcd mRNA is intact (Fig. 5.2).
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Figure 5.1: Design of gfp-bcd transgene. gfp-bcd consists of the bcd promoter, CDS,
introns, 5’ and 3’ UTRs, with an N-terminal GFP tag.

Figure 5.2: Embryonic expression of gfp-bcd transgene. The GFP-tagged Bcd
protein correctly localizes to the anterior of the embryo, forming an A-P concentration
gradient. Image is a composite of 47 optical Z slices (Z step of 0.5 µm) and stitched from
multiple Z stacks. Scale = 25 µm, with 40X magnification.

5.3

E↵ect of miR-305 KO on bicoid mRNA translation in the egg
chamber

To determine if miR-305 activity is required for the repression of bcd translation, we introduced the gfp-bcd transgene into a miR-305 homozygous KO background. The gfp-bcd ;
miR-305 KO/KO and gfp-bcd ovaries were indistinguishable with respect to GFP signal, suggesting that the absence of miR-305 has no detectable e↵ect on the timing of bcd translation
(Fig. 5.3).
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Figure 5.3: A miR-305 KO background does not cause premature gfp-bcd translation. The gfp-bcd transgene was crossed into a homozygous miR-305 KO background, and
ovaries examined for GFP signal. Images are composites of 3-4 optical Z slices
(Z step of 0.5 µm). Scale = 25 µm, with 63X magnification.

5.4

High levels of bicoid mRNA result in its translation in the
egg chamber

We decided to test the idea that by driving high levels of bcd mRNA expression in the egg
chamber, the repressive factors, whether protein or RNA, could be titrated out of the system, resulting in Bcd protein expression. In order to accomplish this, a new transgene was
designed, identical to gfp-bcd except for the bcd promoter replaced with a UAS for Gal4inducible expression (Fig. 5.4).

Figure 5.4: Design of UAS-gfp-bcd transgene. UAS-gfp-bcd is identical to gfp-bcd,
with the exception of the bcd promoter replaced by a 5X UAS sequence.
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To compare the mRNA expression levels of each transgenic line, ovarian RNA was isolated and the levels of bcd mRNA analyzed. A homozygous gfp-bcd line expressed roughly
two times the level of bcd mRNA as the WT, as expected, whereas the UAS-gfp-bcd line,
driven by maternal Gal4, displayed ovarian bcd mRNA levels approximately 15-fold higher
than the WT (Fig. 5.5).

Figure 5.5: Ovarian bicoid mRNA expression levels of gfp-bcd transgenic lines.
Ovaries from the indicated lines were dissected, total RNA isolated, and mRNA levels quantified by qPCR. Histograms represent samples combined from two independent experiments.
To determine if the high levels of bcd mRNA correlated with Bcd protein expression,
ovaries from each fly line were used for immunofluorescence using a Bcd antibody. In the
UAS-gfp-bcd ovaries, robust expression of Bcd protein was detected, localized to nurse cell
nuclei as expected (Fig. 5.6). Bcd was not detected in the WT and gfp-bcd egg chambers,
suggesting that just two additional copies of bcd are not sufficient to cause detectable levels
of protein. We also constructed an identical UAS-gfp-bcd transgene bearing a mutation in
the miR-305 seed binding site. When expression of the WT and seed mutant UAS-gfp-bcd
transgenes were driven with Gal4 in the egg chamber, a modest increase in GFP signal in
the seed mutant egg chambers was observed (Fig. 5.7).
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Figure 5.6: Ovarian protein expression of gfp-bcd transgenes. Ovaries from the indicated lines were dissected, fixed, and probed with anti-Bcd antibody. Images are composites
of 3-4 optical Z slices (Z step of 0.5 µm). Scale = 25 µm, with 63X magnification.
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Figure 5.7: Quantitation of GFP expression from UAS-gfp-bcd transgenes.
(A) Ovaries from the indicated lines were dissected, fixed, and then imaged. Representative
images from the indicated genotypes. Images are composites of 3-4 optical Z slices
(Z step of 0.5 µm). Scale = 25 µm, with 63X magnification. (B) Nuclear GFP fluorescence
levels of each genotype were measured across 10 Z slices using ImageJ software, and plotted
according to developmental stage. N = three independent experiments. Error bars = SD.
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5.5

Pumilio is expressed in the germarium

Because bcd mRNA contains an NRE, we examined whether Pumilio is expressed during
oogenesis. Ovaries from a protein-trapped GFP-Pumilio line (Kyoto DGRC) were fixed and
imaged; consistent with previously published findings (Parisi and Lin, 1999), we observed
Pumilio puncta exclusively in the terminal filament and GSCs (Fig. 5.8). Their di↵erent spatial expression patterns renders it less plausible that Pumilio regulates bcd mRNA
translation during oogenesis.

Figure 5.8: GFP-Pumilio is expressed in the germarium. GFP-Pumilio expression
in the terminal filament and germline stem cells of the germarium (indicated by broken line).
Image represents a single optical Z slice. Scale = 25 µm, with 63X magnification. Simple
schematic of the germarium with terminal filament and germline stem cells indicated (left
panel).

5.6

RNAi screen for repressors of bicoid mRNA translation

Model organism RNAi screens can be used to identify genes that mediate di↵erent biological
processes. One assumption built into the design of our screen is that the removal of individual
repressor proteins would be sufficient for premature/ectopic translation of bcd mRNA in
the egg chamber (Fig. 5.9). We used this knock-down approach to screen genes falling
into several classes: miRNA pathway members, P-body components, general translational
repressors, genes specifically implicated in bcd localization/regulation (Table 5.1). For all of
the knock-downs analyzed, we did not observe any substantial indication that the gfp-bcd
64

transgene is prematurely translated, either from observing raw GFP signal or after probing
with an anti-Bcd antibody.

Figure 5.9: Design of RNAi screen for repressors of bicoid mRNA translation.
The gfp-bcd transgene is introduced into the background of a maternal Gal4 driver. This fly
is then mated with a female bearing an RNAi transgene targeting a chosen gene, and the
progeny of interest (indicated by blue box) are analyzed.
Table 5.1: Genes screened for repressors of bicoid translation
Gene
ago1
gw182
me31b
tral
pacman
ccr4
pop2
cup
bruno
eIf4E-T

5.7

Class
miRNA pathway
miRNA pathway
P-body component
P-body component
5’-3’ exonuclease
3’-5’ deadenylase
3’-5’ deadenylase
translational repressor
translational repressor
translational repressor

Synopsis and Discussion

In this chapter, we outlined the design strategy for two GFP-tagged bcd transgenes which
drive di↵erent expression levels in the egg chamber. We demonstrated that loss of miR-305
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activity in the egg chamber is not sufficient to cause premature translation of bcd, suggesting
either that 1) miR-305 does not play a role in bcd translational repression, or 2) miR-305
cooperates with additional, redundant mechanisms. However, after driving the expression of
bcd at sufficiently high levels, we did observe Bcd protein in nurse cell nuclei. This finding
suggests that oversaturation of ‘repressive’ factors may allow translation of bcd mRNA at a
time period when it is normally translationally silent.

A recurring theme in miRNA research is the ‘fine-tuning’ of target mRNA levels or
translation rates by a miRNA. There are very few examples of miRNA regulation in which
a miRNA controls the translation of its target transcript in a binary manner. One such
example, and incidentally one of the first miRNA-target pairs ever identified, is the case of
the C. elegans lin-4 gene and its target lin-14. It is thought that, in the majority of cases,
miRNAs act either singly or in combination to ‘tune’ mRNA levels depending on cellular
conditions; on this view, miRNAs act to increase the robustness of gene expression.

Our observation that over-expression of bcd mRNA results in Bcd protein translation
in the egg chamber may not seem surprising, but at a minimum it demonstrates that the
mRNA is competent to be translated during oogenesis. One obvious explanation for this
finding, which we favor, is that the high level of bcd mRNA saturates the ‘repressive’ factors
in the germline, allowing some amount of the mRNA to access the translational machinery.
The apparent high level of control over the translational timing of bcd mRNA also raises the
question of its developmental and evolutionary significance. It is conceivable that ectopic
translation of the mRNA during egg chamber development may result in premature activation of Bcd target genes in nurse cell nuclei, or interfere with proper formation of the Bcd
protein gradient in the embryo. These questions can only be properly answered when bcd
translational regulators are identified, which we attempted with our RNAi screen.
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A major limitation of our RNAi screen for repressors of bcd mRNA translation is that
it fails to detect contributions from multiple, partially redundant factors. This may be one
reason that we could not identify any single protein factor as required for bcd mRNA translational repression. However, this is a general feature of most RNAi-based screens. One
alternative possibility would be to perform the screen in a sensitized genetic background, for
example a miR-305 KO/+ genotype. Of course, this assumes that miR-305 does contribute
to bcd translational repression, which may not be the case. Other classically studied patterning transcripts, such as osk mRNA, are regulated by several well-characterized translational
repressors, which cause strong phenotypic e↵ects when mutated. The lack of any similarly
validated repressors of bcd mRNA translation made interpretation of our screen more difficult, for lack of a good positive control.
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Chapter 6
General Discussion and Future Directions

6.1

Evolutionary and functional significance of bicoid mRNA posttranscriptional regulation

The localization and translational regulation of a particular mRNA typically serves a functional role for the organism. For instance, osk mRNA is intricately regulated in order to
limit Oskar protein production to the oocyte posterior beginning at stage 9 of oogenesis;
this regulation is essential for the formation of germ plasm, and consequently germ cells
in early embryos (Appendix). Is there likewise an evolutionary significance underlying bcd
mRNA localization and translational silencing within the D. melanogaster egg chamber?
Interestingly, the bcd gene is recently evolved and found in only a few species of higher flies
outside the Drosophila genus, including the housefly Musca domestica and the blowfly genus
Calliphora (Fig. 6.1). The bcd gene is thought to have originated as a duplication of hox3,
resulting in two genes which diverged and specialized to produce zerknullt (zen) and bcd on
chromosome 3 (Shaw et al, 2001). The functional divergence of zen and bcd explains their different expression patterns in D. melanogaster : zen expressed zygotically and bcd maternally.

There are at least two di↵erent modes of embryonic patterning that exist in insects. In
‘long germ’ model insects, such as D. melanogaster and the wasp Nasonia vitripennis, almost
the complete volume of the mature egg will develop into embryonic tissue. In contrast ‘short
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Figure 6.1: Evolution of the bicoid gene in Dipteran flies. This phylogenetic tree is
adapted from Simpson, 2002. The red box outlines branches of the tree containing species
with a bcd gene. A possible origin point of the bcd gene is also indicated.
germ’ insects, such as the red flour beetle Tribolium castaneum, dedicate only a small portion
of the egg volume to eventual embryonic tissue (Fig. 6.2). This morphological constraint
has two important implications for short germ insects. First, because of the large amount
of extraembryonic tissue present at the anterior of the egg, they typically do not use a maternally localized anterior patterning center in the embryo. Second, the volume of the short
germ embryo is small enough such that a posterior patterning center suffices for embryonic
patterning and development.

It is obvious that the morphology of the D. melanogaster embryo will dictate how sig69

Figure 6.2: Long versus short germ patterning in insects. Schematics describing
the morphology of long and short germ insect embryos, with anterior (A) and posterior (P)
ends indicated (top). Blue dots indicate extra-embryonic tissue. Long germ embryos have
both anterior and posterior patterning centers (indicated by gold stars), whereas short germ
embryos have only a posterior patterning center (bottom). H = head; Th = thorax; Ab =
Abdomen. This figure is adapted from Rosenberg et al, 2009.
naling can proceed during early embryogenesis. Because it is a large syncytial blastoderm,
proteins are free to di↵use along the long axis of the embryo. It is therefore well suited for
an anterior patterning center that utilizes morphogen gradients to activate gene expression.
According to the Synthesis-Di↵usion-Degradation (SDD) model, Bcd protein is translated
from a localized source of bcd mRNA at the embryo’s anterior pole, after which it di↵uses
towards the embryo posterior to form an A-P protein gradient. The rates of di↵usion and
subsequent protein degradation determine the distribution of Bcd along the embryo A-P axis
(Drocco et al, 2012).

Why is there such tight temporal control over bcd mRNA translation? One obvious
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explanation is that earlier translation of bcd mRNA, for instance during egg chamber development, would interfere with the dynamics of Bcd protein di↵usion in the embryo. This
interference would likely occur due to nurse cell dumping, an event in late oogenesis during
which the nurse cells begin apoptosis, transferring and mixing their cytoplasmic contents
into the oocyte. Therefore, it would seem that the more energetically favorable strategy is
one that D. melanogaster employs: anchoring of bcd mRNA to the oocyte anterior pole,
followed by its regulated translation in the early embryo.

6.2

Function of the bicoid Nanos Response Element

In cell reporter assays, we introduced mutations into the bcd NRE to examine whether an
intact NRE sequence is necessary for miR-305 mediated repression. Our reasoning for this
experiment was based on previous work characterizing the NRE as an important secondary
structure that can mediate access for miRNAs. For example, in both D. melanogaster and
human cells, Pumilio binding to the 3’UTR of the E2F3 oncogene enhances the repressive
activity of miRNAs that bind in the local vicinity (Miles et al, 2012). Similarly, in human
fibroblasts, binding of the p27 3’UTR by Pumilio alters the local secondary structure, allowing access for miRs-221 and 222 (Kedde et al, 2010).

The most recent study to examine NRE functionality in the bcd 3’UTR concluded that
mutation of the NRE results in a modest increase in bcd mRNA stability during early embryogenesis (Gamberi et al, 2002). Interestingly, more recent work from a PhD thesis determined that the bcd NRE is bound by Pumilio both in vitro and in vivo, but plays no
physiological role either in bcd mRNA stability or levels of translation during embryogenesis (Nomie, 2009). These studies did not examine Pumilio or bcd NRE function during
oogenesis, however they are consistent with our finding that pum mutant ovaries do not
exhibit an altered pattern of bcd mRNA translation. Furthermore, our observation that
Pumilio and bcd mRNA are not expressed during the same stages of oogenesis also supports
the notion that Pumilio does not substantially contribute to regulation of bcd mRNA in vivo.
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The fact that the bcd NRE is perfectly conserved among 12 Drosophila species suggested
to us that it serves an important regulatory function, and our observation that the NRE
directly overlaps with the predicted miR-305 binding site also strengthened this idea. Interestingly, the NRE is conserved in maternally expressed patterning transcripts from other
insect species. The short germ insect Tribolium lacks bcd, and instead uses orthodenticle
and hunchback to accomplish anterior patterning of the embryo. Tribolium otd-1 mRNA
is supplied maternally and — in contrast to bcd — uniformly distributed throughout the
cytoplasm; it also contains an NRE which causes its targeted decay in the posterior half of
the embryo (Schroder, 2003). This suggests that the NRE has been evolutionarily conserved
for the purpose of embryonic A-P patterning. Why, then, does bcd mRNA contain an NRE
if its expression does not overlap with that of Nanos or Pumilio?

6.3

MicroRNA function in the Drosophila egg chamber

We have presented evidence that miR-305 can regulate bcd mRNA in cell culture and that it
is expressed during oogenesis, consistent with a role in regulating bcd mRNA in vivo. Using
a homozygous miR-305 KO fly, we did not find conclusive evidence that miR-305 impacts
the translational repression of bcd mRNA in the egg chamber. Although it is inconclusive
whether miR-305 plays any role in regulating bcd mRNA, it likely has other targets in the
egg chamber. MiR-305 is a conserved miRNA, with 270 predicted conserved targets according to TargetScan Fly; 131 of these predicted targets are unnamed genes. Of the predicted
named targets, several are expressed during oogenesis, including upf2 and slowmo. Previous work on miR-305 has its activity and possible targets in other fly tissues. In the fat
body, miR-305 targets p53 in response to nutrient signaling (Barrio et al, 2014), and in the
brain, miR-305 has been shown to be required for memory formation (Busto et al, 2015).
The miR-305 homozygous knock-out (KO) fly is viable but it is reported to have a reduced
life span, in addition to an extra bristle phenotype on the dorsal thorax (Foronda et al, 2014).
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Additionally, our small RNAi screen for protein factors that impact bcd mRNA translation did not reveal any convincing hits in the miRNA pathway, such as Ago1 or GW182.
There are several possible explanations for this outcome. First, it is possible that several
protein or RNA factors cooperate in a partially redundant manner to repress translation of
bcd mRNA during oogenesis. This would explain why no single factor produced a result in
the screen. A second, but less likely, possibility is that the amount of Bcd protein produced
by knock-down of a single protein factor was insufficient to detect by direct observation of
GFP signal or immunofluorescence with anti-Bcd antibody. Thirdly, it is also possible that
the miRNA pathway has no role in regulating bcd mRNA stability or translation.

New genetic engineering technologies have facilitated the creation of targeted knock-outs,
particularly for miRNA genes which are small and thus underrepresented using traditional
mutagenesis approaches; this has allowed for a deeper understanding of miRNA biology. A
recent knock-out study of D. melanogaster miRNAs yielded 80 new miRNA mutants, with
80% of these mutants exhibiting at least one abnormal phenotype (Chen et al, 2015). The
nature of miRNA/target interactions allows for an ample amount of redundancy; many different miRNAs can bind one transcript, and a single miRNA is capable of targeting many
di↵erent transcripts. Most miRNA/target interactions are thought to be of the fine tuning variety, with the miRNA slightly decreasing the amount or translational efficiency of a
targeted mRNA. Underscoring the idea of redundancy in miRNA regulatory networks, a systematic deletion screen of individual C. elegans miRNAs, covering 83% of all miRNA genes,
revealed only a small fraction of mutants (7 out of 87) to display any abnormal phenotype
(Miska et al, 2007).

In addition to the 3’UTR reporter assays examining bcd mRNA, we performed assays
using 3’UTRs derived from the maternally expressed genes smaug, hunchback, and string
(cdc25 ) (Fig. 6.3). Based on TargetScan predictions, each gene contained predicted binding
sites for one or more miRNAs for which we have demonstrated expression in ovaries: miR-
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284, miR-8, and miR-956, respectively. Similar to the results from the bcd 3’UTR reporter
assays, we found that each miRNA was capable of repressing its predicted target, and this
regulation was abolished by mutation of the miRNA seed binding site. These results are
merely suggestive of possible miRNA/target interactions that could occur in the egg chamber.

74

Figure 6.3: Maternally expressed transcripts are predicted microRNA targets.
S2 cell luciferase reporter assays demonstrating translational repression of mRNAs by their
predicted targeting miRNAs. For each floating box, the pSiCheck vector is indicated in the
color-coded legend. The co-transfected DsRed vector is indicated on the x-axis. Relative
luciferase (Renilla/Firefly) is indicated on the y-axis. **** = p<0.0001; *** = p<0.001;
** = p<0.01; ns = not significant. N = 12 (combined four technical replicates from each of
three independent experiments. Error bars = SD.
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6.4

Do P-bodies regulate maternal mRNA stability?

We used transgenic RNAi to knock down key components of the mRNA deadenylase and
5’-3’ decay pathways; loss of deadenylase activity, via not1 or pop2 KD, resulted in altered
P-body morphology. Our results indicate that loss of P-body integrity is correlated with a
decrease in the levels of some maternal mRNAs, including bcd and nos (Chapter 3.4-3.6).
This finding seems paradoxical in light of the fact that P-bodies are well characterized as
sites of RNA decay; one would expect an increase in maternal mRNA levels if P-body/RNA
decay activity is compromised.

There are a few idiosyncrasies of D. melanogaster egg development that may partially
explain our observations. First, bcd mRNA is known to be very stable over the course of
oogenesis (Surdej and Jacobs-Lorena, 1998). It is therefore unlikely that RNA decay plays
a substantial role in its normal life cycle during development of the mature egg. Second,
the P-body component Me31B is already well known to exist in particles with many maternally expressed transcripts, including the localized mRNAs osk, bcd, and nos. Disruption of
P-bodies, and consequently Me31B/RNA particles, may interfere with normal mRNP formation for several of these transcripts. Third, immuno-EM experiments on D. melanogaster
egg chambers have revealed P-bodies to be structured and compartmentalized, with certain
transcripts, such as bcd, retained in the ‘core’ and others positioned more closely to the
P-body periphery (Davidson et al, 2016). It is possible that disruption of P-body formation interferes with this structuring, allowing components of the 5’-3’ decay machinery close
proximity to mRNAs to which they otherwise would not have access. Therefore, when either P-body formation or composition is compromised (e.g. through our RNAi KDs), these
maternal transcripts undergo some form of unregulated RNA decay.

Consistent with this hypothesis is a recent publication reporting that in mutants of
Drosophila Cup, an eIF4E-binding protein that is also considered a P-body component,
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oskar mRNA levels are significantly decreased (Broyer et al, 2016). This finding suggests,
that in some contexts, P-bodies can play a role in stabilizing maternal transcripts.

6.5

P-bodies and translational control of bicoid mRNA

In contrast to the other classic patterning transcripts of the D. melanogaster egg chamber,
bcd mRNA is not translated until early embryogenesis. How this timing is achieved was one
of the questions motivating this thesis. Previous work in this system has shown that disassembly of P-bodies after egg activation is tightly correlated with translation of bcd mRNA;
this suggests that removal of bcd mRNA from P-bodies is a key precursor event to its translation (Weil et al, 2012). It is possible that incorporation of bcd mRNA into P-bodies is
mediated by multiple protein factors, and that once incorporated into a P-body, bcd mRNA
is e↵ectively shielded from the translational machinery for the duration of oogenesis. This
would explain why removal of miR-305 or knock-down of miRNA pathway factors had no
detectable e↵ect on the timing of bcd mRNA translation. However, this hypothesis is also
countered by the fact that knock-down of me31b had no observable e↵ect on translation of
bcd in the egg chamber.

A possible mechanism for translational repression of bcd mRNA is via bcd ’s sequestration
in P-bodies, which exclude the translational machinery and ribosomes. Consistent with this
possibility is our finding that overexpression of bcd with the UAS-gfp-bcd transgene results
in Bcd protein translation in the egg chamber. It would be interesting to analyze the subcellular distribution of the transgenic bcd mRNA, to observe whether it is present outside of
P-bodies. Perhaps oversaturation of P-bodies with high levels of bcd results in access of bcd
mRNA to the translational machinery.

This raises the question of how bcd mRNA is sequestered within P-bodies during the
normal course of its life cycle in the egg chamber. Because P-bodies are composed of many
di↵erent proteins, the aggregation of many mRNA species and their trans-acting factors re77

sults in P-body formation. The fact that bcd mRNA is present within the P-body ‘core’ may
simply be a consequence of bcd ’s particular protein associations, rather than any active process of regulation. Overexpression of bcd mRNA would likely interfere with the stoichiometry
of mRNA/protein interactions, shifting the equilibrium towards bcd mRNA being present
outside of P-bodies. However, this outcome would also depend on whether P-body/bcd associated proteins are in large excess or which are limiting factors in this interaction.

6.6
6.6.1

Future Directions
MiR-305 function in the egg chamber and embryo

Because miR-305 is deposited maternally, it can possibly function during early embryogenesis
rather than oogenesis. It would be interesting to more closely analyze maternal and zygotic
miR-305 mutant embryos for defects in patterning, for instance in the expression patterns
of pair rule genes. It is also possible that miR-305 acts to degrade bcd mRNA in the early
embryo, after the developmental window for its translation has ended.

6.6.2

Screen for repressors of bicoid mRNA translation

Our screen for repressors of bcd mRNA translation was performed in a genetic background
containing one copy of a gfp-bcd transgene and two endogenous copies of bcd. An alternate
possibility would be to perform a similar screen in a sensitized background, for example
containing only one WT copy of miR-305. This approach may be more likely to bypass
redundant interactions that possibly occur in a WT physiological setting. Another possibility
is a genetic background which is compromised for bcd mRNA localization, for example
in a stau mutant. This approach may uncover interactions between proper bcd mRNA
localization and its translational repression.
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6.6.3

Does bicoid exist in mRNPs with other mRNA species?

Several trans-acting protein factors that interact with bcd mRNA have been well characterized (Chapter 1.3), however a question that has gone almost completely unaddressed is the
mRNA composition of bcd particles in the egg chamber. Our lab has acquired preliminary
imaging data demonstrating that bcd and osk mRNAs co-exist in particles in the egg chamber nurse cells. One interesting avenue of investigation would be to examine the functional
significance of bcd /osk particle formation. For example, is formation of these particles necessary for proper translational regulation of each transcript? This could be partly explored
by overexpressing bcd mRNA — using the UAS-gfp-bcd transgene — and then examining
whether bcd and osk mRNA co-localization is altered.

6.6.4

P-body morphology and compartmentalization of mRNPs

Previous work on egg chamber P-bodies suggests that P-bodies are structured, with certain
mRNPs preferentially localized to discrete locations, such as the core or periphery. One
possible avenue for investigating this phenomenon would be the use of immuno-EM imaging
in combination with RNAi knock-down of di↵erent P-body components, to examine how
compromising the activity of individual component proteins a↵ects the overall morphology
and distribution of transcripts within the P-body. These experiments would also help address
the hypothesis we o↵ered in Chapter 6.4 for explaining the decreased levels of maternal
transcripts when P-body morphology is compromised.
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Chapter 7
Materials and Methods

7.1

Fly lines

Table 7.1: Gal4-inducible RNAi lines from the Bloomington Drosophila Stock
Center
Gene name
mCherry TRiP
ago1 TRiP
tral TRiP
me31b TRiP
gw182 TRiP
pacman TRiP
ccr4 (twin) TRiP
not1 TRiP
pop2 TRiP
thor (4E-T ) TRiP
staufen TRiP

Stock number
35785
33727
38908
38923
34796
34690
32490
32836
52947
36815
43187

Table 7.2: Gal4 driver lines from the Bloomington Drosophila Stock Center
Common name
Gal4 7063
Gal4 4442
Gal4 7062

Genotype
w⇤ ; P[mat↵-GAL4-VP16]V37
y1 w⇤ ; P[GAL4-nos.NGT]40
w⇤ ; P[mat↵-GAL4-VP16]V2H
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Stock number
7063
4442
7062

Table 7.3: Lines constructed in the lab
Common name
Double-balancer
me31b-yfp ; Gal4 7063
Gal4 7062 ; tral-gfp
gfp-bcd
UAS-gfp-bcd

Genotype
Sp/Cyo ; Ki/Sb, Ser
me31b-yfp/Cyo ; P[mat↵-GAL4-VP16]V37
P[mat↵-GAL4-VP16]V2H ; tral-gfp
w*, gfp-bcd
w* ; UAS-gfp-bcd

Table 7.4: Lines from the Kyoto Drosophila Stock Center
Name
me31b-yfp
tral-gfp
pum-gfp

7.2

Stock number
115460
115090
115589

Luciferase reporter assays

Luciferase assays were performed as previously described (Okamura et al, 2007). Briefly,
the DsRed-miRNA and pSiCheck vectors were co-transfected into Drosophila S2 cells using
E↵ectene transfection reagent (Qiagen) and plated at a density of 1.1-1.2 x 106 cells/ml.
Cells were incubated for three days at room temperature, lysed, and both Renilla and firefly
luciferase levels measured by luminometer.

7.3

Cloning

UAS-gfp-bcd

A plasmid containing the complete bicoid locus bearing an N-terminal GFP tag was a
gift from Thomas Gregor, Princeton University (Gregor et al, 2007). Primers spanning the
bicoid 5’ UTR and 1 kb downstream of the annotated 3’ UTR were used to clone the bicoid
transgene into the pENTR/D-TOPO vector (Gateway system). Using the Gateway system,
this transgene was then recombined into a modified UASp vector (gift from Jennifer Zallen
lab, Memorial Sloan Kettering Cancer Center) to produce UAS-gfp-bcd for expression in the
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germline.

gfp-bcd

Primers spanning 200 nt of the bcd promoter sequence and 1 kb downstream of the
annotated 3’ UTR were used to clone bicoid into pBID-G (Addgene # 35195), which was
then transformed onto the X chromosome using the Phi-C31 Integrase system.

pSiCheck-bicoid 3’ UTR

The full bcd 3’ UTR was cloned into the pSiCheck 2 vector (Promega) using Xho1 and
Not1 sites. Mutagenesis was performed by PCR using mismatched primers and verified by
sequencing (Genewiz). Mutagenic primer sequences are included in the Methods section.

7.4

RNA isolation

Dissected ovaries were washed one time with 1X PBS and homogenized in Trizol. Total
RNA was isolated according to the manufacturer’s instructions. Following extraction, the
total RNA was washed twice in 75% ethanol and stored in H2O at -20 C.

7.5

RT-qPCR

Reverse transcription reactions were performed as follows:
For miRNA amplification, 100 ng of small RNA was incubated with 2 pM RT primer at
70 C for 5 minutes, cooled on ice for 5 minutes, followed by addition of RT enzyme and
incubation at 42 C for 1 hour. For amplification of mRNA targets, the protocol was identical except that 250 ng of RNA was incubated with 0.5 µg of dT or random hexamers primer.
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qPCR reactions were performed in a Roche Lightcycler 480 as follows:
Each PCR reaction contained 1 µl of cDNA from RT reaction, 2 µl primer solution (10 µM
forward and reverse), 2 µl dH2O, and 5 µl SYBR Green.
95 C denaturation for 5 minutes, followed by 40 cycles of
95 C for 20 seconds
58 C for 15 seconds
58 C for 15 seconds

7.6

Ovary dissection and fixation

Following dissection in 1X PBS, ovaries were washed in 1X PBS and then incubated for 15
minutes while rocking in 4% paraformaldehyde (PFA) in 1X PBS. Ovaries were then washed
4x 5 minutes in 1X PBS with 0.05% Triton X-100.

7.7

Fluorescence in situ hybridization

Ovaries were fixed, washed, and then smFISH was performed using bicoid -specific Stellaris
RNA FISH probes (Biosearch Technologies). The protocol is described in Bayer et al, 2015.

7.8

Immunofluorescence

Dissected ovaries were fixed and then permeabilized in 1% Triton X-100, 1% BSA, with 1X
PBS for 2 hours, then washed with 1X PBS. Primary antibodies were incubated overnight at
room temperature or 4 C in 0.3% Triton X-100, 0.1% BSA with 1X PBS, and then washed
4X in 0.05% Triton X-100, 0.1% BSA with 1X PBS. Secondary antibody was incubated at
1:1000 dilution for at least 2 hours at room temperature. Ovaries were then washed 4X in
1X PBS with 0.05% Triton X-100 and mounted with Prolong Gold media.
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7.9

Confocal microscopy

Imaging was performed with a Leica DMI-4000B inverted microscope with a Yokogawa
CSU 10 spinning disk head and Hamamatsu C9100-13 ImagEM EMCCD camera.

7.10

Image analysis

Image processing and analysis were performed using the NIH’s ImageJ software
(https://imagej.nih.gov/ij).

7.11

Western Blotting

Ovaries were lysed mechanically with CytoBuster lysis bu↵er plus protease inhibitor cocktail.
Protein samples were run on an 8% SDS-MES polyacrylamide gel, transferred to a nitrocellulose membrane, and probed with appropriate primary antibodies overnight at 4 C.
Membranes were washed and then probed with fluorescent or HRP conjugated secondary
antibodies, and imaged accordingly.

7.12

Oligonucleotide sequences and antibodies

Table 7.5: Oligo sequences for Gateway cloning
Target gene
gfp-bcd fwd
gfp-bcd rev
gfp-bcd endogenous promoter fwd

Sequence
caccatctcttcgctcatccctaaataacggcactctgcagatgcg
agttagtcacaatttacccgagtagagtagttcttatatattttcgt
caccgtctaa aatgtattgtagacgcttattg
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Table 7.6: Oligo sequences for qPCR (FlyRnai.org “Fly Primer Bank”)
Target gene
bcd PD44122 fwd
bcd PD44122 rev
osk PP3222 fwd
osk PP3222 rev
nos PP15723 fwd
nos PP15723 rev
cdk9 PP5417 fwd
cdk9 PP5417 rev
hetA fwd
hetA rev
rp49 fwd
rp49 rev

Sequence
tgagcaccggaataagagcc
ggcgttccgatggggattat
atgaccatcatcgagagcaact
gtggctcagcaatatggcg
ctcgtcggccactttgagtc
ctgtcggccagaaaagggaag
cgatgtccctgatggagaaac
ccaattttcgccaccttttcgta
cgcgcggaacccatcttcaga
cgccgcagtcgtttggtgagt
aagcccaagggtatcgacaacaga
tcgacaatctccttgcgcttcttg

Table 7.7: Oligo sequences for sequencing of gfp-bcd transgenes
Target gene
gfp-bcd seq1
gfp-bcd seq2
gfp-bcd seq3
gfp-bcd seq4
gfp-bcd seq5
gfp-bcd seq6
gfp-bcd seq7

Sequence
atctcttcgctcatccctaaata
cgcatcgagctgaagggc
aattccgaaatcccttcgatttg
gcccaaccagatgcccaag
gcaggtccataatcaccagca
ccgatcgatgagatttgggag
cagtttgcctactgcttcaatta

Table 7.8: Oligo sequences for restriction digest cloning
Gene name
bicoid 3’UTR fwd
bicoid 3’UTR rev
string (cdc25 ) 3’UTR fwd
string (cdc25 ) 3’UTR rev
smaug 3’UTR fwd
smaug 3’UTR rev
hunchback 3’UTR fwd
hunchback 3’UTR rev

Primer sequence
ttatcctcgagcctggatgagaggcgtgttagagagtttcattagc
ttatcttgcggccgcgtagttagtcacaatttacccgagtagagtagttcttata
ttatcctcgaggttgtgggatgatcgtgcagttcgttatctaag
ttatcttgcggccgccgtcgtgtattaatgtatatttaaaattgatgg
ttatcctcgagaccccaatcacaacatcaactatttcattcacta
ttatcttgcggccgctatcccaactggccgtacaataggtttttatta
ttatcctcgaggttccccatcaccatcaccttgttattattattta
ttatcttgcggccgcatattgaataattggatttatttgatttgatttcgttc

85

Table 7.9: Oligo sequences for mutagenesis by PCR
Mutation name
bcd NRE Box A fwd
bcd NRE Box A rev
bcd NRE Box B(1) fwd
bcd NRE Box B(1) rev
bcd NRE Box B(2) fwd
bcd NRE Box B(2) rev
bcd 305 seed fwd
bcd 305 seed rev
305 comp c7g fwd
305 comp c7g rev
305* comp g15c fwd
305* comp g15c rev
smg 284 site 2 fwd
smg 284 site 2 rev
stg 965 site fwd
stg 965 site rev
hb 8 site fwd
hb 8 site rev

Primer sequence
agagagtttcattagctttaggttaaccactcatgttcctgattgtaca
tgtacaatcaggaacatgagtggttaacctaaagctaatgaaactctct
ctttaggttaaccactgttgttcctgatactacaaataccaagtgattgtag
ctacaatcacttggtatttgtagtatcaggaacaacagtggttaacctaaag
tgttgttcctgattgtacaaataccaagtgatactagatatctacgcgtag
ctacgcgtagatatctagtatcacttggtatttgtacaatcaggaacaaca
cattagctttaggttaaccactgttgttcctgattgtagttttaccaagtgattgtagat
atctacaatcacttggtaaaactacaatcaggaacaacagtggttaacctaaagctaatg
tgtctcccatgtctattgtagttcatcaggtgctc
gagcacctgatgaactacaatagacatgggagaca
cgtaacccggcacatgttgaactacactcaatatga
tcatattgagtgtagttcaacatgtgccgggttacg
tacacataatttattttaaattaaaaggaacatatttcgtcaaccgtaactgcaccagag
ctctggtgcagttacggttgacgaaatatgttccttttaatttaaaataaattatgtgta
gttgtaaacttctgctaggtacaatttagcgttattatttgtttatttttatgtaatccg
cggattacataaaaataaacaaataataacgctaaattgtacctagcagaagtttacaac
ctcagttctttctctgatattattctctgacttttttgttagttgaaagcgaattcgaat
attcgaattcgctttcaactaacaaaaaagtcagagaataatatcagagaaagaactgag

Table 7.10: Oligo sequences for miRNA qPCR
Target miRNA
miR-305 RT
miR-305 fwd
miR-284 RT
miR-284 fwd
miR-8 RT
miR-8 fwd
miR-2b RT
miR-2b fwd
miR-965 RT
miR-965 fwd
miR-280 RT
miR-280 fwd

Sequence
gtcgtatccagtgcagggtccgaggtattcgcactggatacgaccagagc
gcgattgtacttcatcaggtg
gtcgtatccagtgcagggtccgaggtattcgcactggatacgactgctg
gtcagcaacttgattccagc
gtcgtatccagtgcagggtccgaggtattcgcactggatacgacgacat
taatactgtcaggtaaagatgtc
gtcgtatccagtgcagggtccgaggtattcgcactggatacgacgctcct
gctatcacagccagctttga
gtcgtatccagtgcagggtccgaggtattcgcactggatacgacaaggg
taagcgtatagcttttcccc
gtcgtatccagtgcagggtccgaggtattcgcactggatacgactatcat
gctgtatttacgttgcatatgaaatg

Table 7.11: Antibodies used for Immunofluorescence and Western Blotting
Name
Bicoid
GFP
Alpha-tubulin

Retailer
Santa Cruz Biotechnologies
Millipore
Millipore
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Species
rabbit
rabbit
mouse
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Chapter 1
Drosophila melanogaster Oogenesis: An Overview
John M. McLaughlin and Diana P. Bratu
Abstract
The Drosophila melanogaster ovary has served as a popular and successful model for understanding a wide
range of biological processes: stem cell function, germ cell development, meiosis, cell migration, morphogenesis, cell death, intercellular signaling, mRNA localization, and translational control. This review
provides a brief introduction to Drosophila oogenesis, along with a survey of its diverse biological topics
and the advanced genetic tools that continue to make this a popular developmental model system.
Key words Flp-FRT, Patterning, Follicle cells, Morphogenesis, Germ plasm, Mosaics, P element,
RNAi, Drosophila, Oogenesis, Oocyte, mRNA localization, Gal4, Live, Imaging, CRISPR,
Fluorescence

1

Ovary Structure in Insects and Higher Flies
The Drosophila genus, which includes D. melanogaster, is a member
of the order Diptera, or the higher flies. As a holometabolous
insect, Drosophila undergoes a complete metamorphosis, including
a transition from larval to pupal form; the complete life cycle consists
of four stages [1].
In the class Insecta, several ovarian morphologies have evolved,
each of which utilizes a different organizational layout for oocyte
development (Fig. 1). In the majority of examined cases, basal
insects contain panoistic ovaries, in which oogonia, ensheathed
by follicular cells, mature into oocytes in the absence of additional
support cells [2]. In contrast, higher insects have meroistic ovaries in
which support cells linked to the oocyte provide it with large
amounts of mRNA, protein and other cellular material [3].
Meroistic ovarian morphology is further subdivided into two categories. Telotrophic meroistic oocytes maintain connections to
support cells via a nutritive cord that extends anteriorly through the
ovariole to the germarium. The support cells remain localized
at the anterior end of the ovariole throughout oogenesis. In contrast, polytrophic meroistic oocytes are connected directly to
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Fig. 1 Three distinct organizations of insect ovaries. Schematic representation of ovarioles derived from
panoistic, telotrophic meroistic, and polytrophic meroistic ovaries (anterior—top; posterior—bottom). The germarium region, somatic follicle cells, support/nurse cells, and the developing oocyte are indicated within each
ovariole chain

adjacent supporting nurse cells by cytoplasmic junctions (ring canals).
In this system, the entire cyst moves as a unit through the ovariole;
this is the strategy utilized by Drosophila species.
The basic unit of the ovary is the ovariole; there are 16–20
ovarioles per ovary, each being autonomous and containing its
own stem cell populations and egg chambers at varying developmental stages. The ovariole can be divided into three principal
regions (from anterior–posterior): the terminal filament, germarium, and vitellarium (reviewed in ref. 4). The terminal filament
(TF) consists of a stack of 8–9 flattened cells which connect the
germarium to the surrounding ovariole sheath and determine the
orientation of ovariole development [5]. The germarium is divided
into four regions (1, 2a, 2b, and 3) and is the site of germline
stem cell (GSC) division, differentiation, and germline cyst formation. In germarium region 3, the germline cyst, containing nurse
cells and oocyte, is ensheathed by a somatic cell layer (becoming an
egg chamber) before being passed into the vitellarium [4]. The
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remaining development of the egg chamber, including vitellogenesis
and choriogenesis, is completed in the vitellarium [4]. The entire
process of oogenesis is thus divided into 14 morphologically distinct stages.

2

Stem Cell Compartmentalization Within the Germarium
Stem cells are essential in many adult organs to provide a localized
renewed source of differentiated cells, thereby maintaining tissue
homeostasis; they reside in “niches” in specific anatomical locations which contribute to their proper maintenance and function.
The D. melanogaster ovary contains two main stem cell populations, the germline (GSC) and follicle stem cells (FSC), which
collectively give rise to the nurse cells, oocyte, and follicle cells of
the mature egg chamber. Each stem cell population resides in a
unique, specialized niche containing several types of support cells
(reviewed in ref. 6).
The niche microenvironment is essential for the regulated balance between stem cell self-renewal and differentiation. In the case
of ovarian stem cell niches, this is achieved by both an array of
secreted signaling molecules and direct adhesive connections
between stem cells and their niche components ([7, 8] and
reviewed in refs. 9, 10). The germline stem cell niche resides at the
anterior tip of the germarium; it contains 2–3 GSCs and their support cells, the cap (CC) and TF cells [9] (Fig. 2a). GSCs can be
reliably identified by their direct anchorage to CCs, and by the
presence of an anteriorly localized spectrosome (also known as the
fusome in cystocytes). In addition to CCs, the GSCs require escort
cells (ECs, also known as inner germarial sheath cells) for their
regulated differentiation; ECs are glial-like cells which surround
germline cysts with cytoplasmic processes, preventing adjacent
cysts from making direct contact [11, 12]. In the anterior half of
the germarium, germline cysts are surrounded by ECs before they
migrate posteriorly and become ensheathed by an epithelial follicle
cell layer [12]. While CCs act to prevent GSC differentiation and
promote self-renewal, the ECs support their differentiation [13].
Collectively, the CCs, TFs, and ECs constitute the complete niche
for GSCs (reviewed in ref. 14).
Technical advances in live tissue culture have made it possible
to visualize ovarian stem cells in their in vivo niche environments
[15]. This has yielded insight into the dynamic interactions among
stem cells and their niche components, which would otherwise be
impossible to elucidate from fixed samples. For example, it was
recently demonstrated by live imaging that ECs do not migrate
with their encircled cyst, but rather use their cellular extensions to
“pass” developing cysts posteriorly through the germarium [15].
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Fig. 2 The germarium and mid-stage egg chamber: Structure and cell
types. (a) A diagram of the cells housed in the germarium. They illustrate the
initial GSC division, formation of the germline cyst, and its enclosure by a layer of
follicle cells. Each cell type is denoted by its corresponding color in the key. (b)
During stage 10, the oocyte encompasses about 50 % of the egg chamber, with
the follicle cells surrounding the oocyte having a columnar morphology, in contrast to the squamous follicle cells covering the nurse cells compartment. Ring
canals (green) bridge the cytoplasm of adjacent nurse cells and the oocyte. At
this stage, border cells (yellow) have completed their migration from the anterior
of the egg chamber towards the oocyte. The oocyte nucleus (purple) is localized
to the dorsal anterior quadrant, along with gurken mRNA (orange). bicoid (blue)
and oskar (red) mRNAs are localized at the anterior and posterior cortex of the
oocyte, respectively
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Cystoblast Division, Oocyte Differentiation, and Formation of the Egg Chamber
A differentiated GSC is termed a cystoblast (CB); this CB will
divide a total of four times to produce 16 cystocytes. Each mitotic
division is accompanied by incomplete cytokinesis, forming intercellular cytoplasmic bridges near the mitotic spindle called ring
canals [16]. The invariant pattern of cystocyte division and ring
canal formation was dissected in the 1960s through light and electron microscopy of sectioned ovaries [16]. Central to this process
is the fusome, a specialized cytoplasmic organelle composed of
skeletal membranous proteins, which helps form and maintain ring
canals following each mitotic division (reviewed in refs. 17, 18).
The nurse cell ring canals are composed of F-actin and accessory
proteins [19], including the actin-binding protein Anillin, which is
required for the earliest stages of ring canal development in the egg
chamber [20]. Additional proteins are localized to the actin rings
and necessary for later stages of nurse cell formation [21].
The determination of the oocyte from among the 16 cells of
the cyst involves a series of “symmetry breaking” events beginning
at the first CB division. The germarium is divided into discrete
regions, which indicate the developmental stage of the nascent
germline cyst and its oocyte. Region 1 of the germarium contains
the GSC niche and germline cysts of 2, 4, or 8 cells; region 2a
contains 16 cell germline cysts in which two pro-oocytes are determined [22]. At the time of egg chamber entry into region 2b of
the germarium, the oocyte has been specified and can be distinguished by the presence of several mRNA and protein markers
[23–25]. An intact, polarized microtubule (MT) cytoskeleton is
also required for differentiation of the oocyte, as well as the localization of oocyte-specific markers. In the absence of an intact MT
cytoskeleton, such as following colchicine treatment, the oocyte
fails to differentiate and an egg chamber containing 16 nurse cells
is formed. One model for oocyte differentiation proposes that the
oocyte is always formed from the cystoblast inheriting the most
fusome from the first mitotic division [26]. In region 3 of the germarium, the germline cyst (egg chamber) is almost completely
ensheathed by an epithelial follicle cell layer. The budding of the
egg chamber from the germarium marks stage 1 of oogenesis
(reviewed in ref. 27).

4

Follicle Cell Development
The somatic follicle cells of the egg chamber originate from a pair
of stem cell niches, positioned laterally on each side of the germarium
between regions 2a and 2b [28]. These niches contain the follicle
stem cells and make direct contact with ECs that are required for
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maintenance of the FC niche [29]. There is regulatory overlap
between the GSC and FSC niches, as FSCs also require secreted
signaling molecules from the CCs to maintain their self-renewal
capacity [30–32]. Three distinct types of follicle cell are formed
during egg chamber development: polar cells, stalk cells, and epithelial follicle cells [33]. Polar cells are located at the anterior and
posterior tips of each egg chamber, while stalk cells connect and
bridge adjacent egg chambers; both populations originate from
the same precursor follicle cell lineage [34]. By the end of stage 5,
there are two polar cells at each egg chamber terminus; these cells,
along with the TGF-α homolog Gurken protein, participate in signaling events that determine the egg chamber posterior pole and
induce the reorganization of the MT cytoskeleton during midoogenesis [35].
The epithelial follicle cells ensheath the entire egg chamber
and compose the bulk of the total follicle cell population; beginning
at stage 1 of oogenesis, they can be distinguished on the basis of
specific protein markers [36]. These cells are further subdivided
into two categories: terminal follicular cells, which are contained
within an area of ~10 cell diameters from each egg chamber pole,
and mainbody follicular cells which cover the lateral surface area
of the germline cyst (reviewed in ref. 33). The terminal follicle cells
are specified by secreted signals from polar cells [37]. Until stage
6, the follicle cells proliferate by mitosis giving rise to a maximum
number of ~1000 cells surrounding the egg chamber [38].

5

Cell Migration and Egg Chamber Morphogenesis
The development of a complex structure such as the egg chamber
requires cell migratory and morphogenetic events; at various
developmental stages, different cell populations within the egg
chamber contribute to processes that are necessary for egg chamber development. One such migratory event is the long-range
movement of border cells during mid-to-late oogenesis. Border
cells are specified from a small population of terminal follicle cells
at the egg chamber anterior, via secretion by adjacent polar cells of
the Unpaired (Upd) ligand [39]. This population of 6–8 cells then
detaches from their neighboring FCs, migrates between nurse cells
towards the egg chamber posterior, and inserts into the dorsal side
of the oocyte to form the micropyle [40]. Recent developments in
ex vivo culturing techniques and live imaging have made border
cell migration a popular model for the study of cell movement in
general, as well as the related process of cancer metastasis [41].
During the same developmental time period as border cell
migration, the epithelial follicle cells also undergo migration as
well as morphological change. Before stage 9, most FCs are
cuboidal in shape (reviewed in ref. 42). The mainbody follicular
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cells migrate posteriorly to surround the oocyte, at the same time
adopting a columnar morphology [37]. These cells then secrete
eggshell components onto the underlying oocyte membrane [33].
The anterior terminal FCs undergo a “flattening” that creates a
squamous morphology, covering the nurse cell compartment of
the egg chamber; this flattening event involves a remodeling of
existing cell junctions [43]. Following these migratory and cell
shape changes during stages 9–10, there is a characteristic demarcation between squamous and columnar FC morphologies at the
nurse cell-oocyte junction [42].
One additional and striking example of a large-scale morphogenetic change during oogenesis is the recently characterized
mechanism by which the egg chamber progressively elongates
along its A-P axis. Through live imaging, it was demonstrated that
the follicular epithelium rotates circumferentially around the A-P
axis of the egg chamber, in the process depositing a polarized
matrix of collagen and other extracellular matrix proteins. This
matrix acts as a “corset” which physically constricts the egg chamber
and causes its elongation in the A-P direction ([44] and reviewed
in refs. 45, 46).

6

Cell Cycle Regulation and Meiosis
The several distinct cell types of the ovary differ in the regulation
of their cell cycles. However, one similarity between the nurse and
follicle cells is their use of endocycles (also known as endoreduplication or endoreplication): DNA synthesis (S) and gap phases
without an intervening mitosis or cell division (reviewed in refs.
47, 48). The resulting polyploidy allows cells to increase their
quantity of mRNA and protein production, which is essential for
oocyte growth and development. Follicle cells typically undergo six
to eight endocycles, while nurse cells undergo 10–12 ([49] and
reviewed in ref. 50). Beginning at stage 10b, the follicle cells
surrounding the oocyte cease normal endocycles and begin gene
amplification cycles (this event is termed the E/A switch). Four
specific genomic loci, encoding genes involved in chorion (eggshell)
and vitelline membrane synthesis, are amplified from 4 to 80-fold
[47, 51]. This allows for the production of high levels of chorionrelated proteins.
The oocyte undergoes both developmental maturation and
meiosis throughout the course of oogenesis, and these processes
are intimately linked. Meiotic double-stranded breaks must be
repaired in order to maintain the integrity of the MT cytoskeleton
and proper translational control of localized mRNAs [52, 53]. The
balance of oocyte differentiation and progression through meiosis
is achieved by two major meiotic checkpoints in oogenesis.
Prophase I of meiosis begins early in egg chamber development, in
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region 2a of the germarium, and is indicated by the presence of the
synaptonemal complex in the two pro-oocytes (reviewed in refs.
54, 55). Beginning at stage 5, the oocyte arrests in diplotene stage
of prophase I; this arrest lasts until roughly stage 13, at which point
meiosis progresses to metaphase I [53]. A metaphase I arrest occurs
at stage 14, and is maintained until egg activation triggers the
resumption and completion of meiosis [53]. Egg activation in
Drosophila occurs independently of fertilization, and is triggered
instead by mechanical pressure on the oocyte during passage into
the oviduct [56].

7

mRNA Localization in the Egg Chamber
One of the well-studied processes occurring during D. melanogaster oogenesis is the localization and translational control of the key
embryonic patterning transcripts. As a result of the pioneering
work of Wieschaus and Nusslein-Volhard on the genetic control of
D. melanogaster embryonic patterning [57], the late 1980s and
early 1990s saw a flurry of publications on oocyte-localized mRNAs
and their involvement in different aspects of germ plasm formation
and embryonic development [58–60]. The mRNAs mainly responsible for patterning of the early embryo, oskar, bicoid, gurken, and
nanos, are each localized to a distinct compartment of the oocyte
before fertilization (reviewed in refs. 61–63) (Fig. 2b). The large
size of the egg chamber’s nurse cell and oocyte compartments
demands that mRNA is transported long distances. This process
requires the microtubule and actin cytoskeletons as well as various
trans-acting proteins that affect their transport, localization, and stability [64]. Advances in imaging technology have also made this an
ideal system for investigating live trafficking of mRNAs [40, 65].
One example of a long-distance traveling transcript is oskar
(osk) mRNA, which encodes the D. melanogaster germline determinant. osk was cloned in the early 1990s and shown to be localized as mRNA to the oocyte posterior pole [58, 59]. Genetic
analyses conducted over the past 20 years have identified some of
the protein factors required for transport and translational control
of osk (and other mRNAs), including the RNA-binding protein
Bruno [66, 67]. Live imaging studies of osk mRNA have shed light
on the dynamic nature of the mRNA transport process [68, 69],
and helped to refine models on how the localization of mRNA is
achieved in large, complex tissues [70]. The oocyte MT cytoskeleton, and its interactions with mRNA and other cellular cargoes,
has also been studied using live imaging techniques [71, 72]. One
such study, using fluorescently labeled RNA injected into live
oocytes, demonstrated the necessity of Exuperantia protein for the
anterior transport of bicoid mRNA in the oocyte [73].
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Formation and Function of Germ plasm
There are two main strategies for specifying germ cells during animal development: cytoplasmic inheritance of germline determinants (also known as preformation) or zygotic induction
(epigenesis) of germ cell fate. Most insects use the inductive
method, in which germ cells are specified during embryogenesis by
signals from adjacent somatic cells [74]. In contrast, the holometabolous insects, including Drosophila species, employ the preformative method of germ cell specification. In this developmental
mode, germline determinants, in the form of germ plasm (also
known as pole plasm), are inherited maternally and specify germ
cells during early embryonic development (reviewed in ref. 75).
The germ plasm is a specialized cytoplasm, assembled at the
oocyte posterior pole; it has been studied for its role in germ cell
determination in insects and other animals for over 100 years ([76]
and reviewed in ref. 77). Germ plasm is characterized by the presence of polar granules, non-membranous electron-dense organelles containing mRNA, protein, ribosomes, and noncoding RNA,
most notably the mitochondrial large ribosomal RNA (reviewed in
refs. 78, 79). Three classes of proteins are highly represented in the
Drosophila germ plasm: Tudor-domain containing proteins (e.g.,
Tudor), DEAD-box RNA helicases (e.g., Vasa), and Piwi family
proteins (e.g., Aubergine) (reviewed in ref. 80). In addition, interactions between Tudor domain and Piwi proteins are important for
assembly of the germplasm in Drosophila [81].
One of the critical upstream factors required for germ plasm
formation is osk mRNA. Upon its localization to the oocyte posterior, osk is translated. Genetic manipulations or mutations causing
mislocalization of osk to the oocyte anterior result in ectopic formation of germ cells at the anterior of the embryo ([82] and
reviewed in refs. 83, 84). The use of two alternative translation
start sites in osk mRNA produces two Oskar protein isoforms:
Short Osk and Long Osk. The short isoform initiates formation of
the germ plasm ([85] and reviewed in refs. 27, 78, 86), while Long
Osk is required for the posterior anchoring of both Short Osk and
osk mRNA. Loss of Long Osk from egg chambers causes dispersion
of Short Osk from the oocyte posterior pole and a reduced number
of pole cells formed during embryogenesis [87]. Classic transplantation experiments, in which a fraction of early embryonic germ
plasm is transferred to the anterior pole of a separate embryo, first
demonstrated the sufficiency of germ plasm for germ cell specification [88].
The germ plasm’s functional role begins ~1.5 h into embryonic development, at which point ~10 pole cells are formed from
the cellularization of posteriorly localized nuclei and the surrounding germline determinants. These are the first cells formed in the

10

John M. McLaughlin and Diana P. Bratu

blastoderm embryo; they will be carried into the embryo during
gastrulation and eventually migrate to form the primordial germ
cells of the gonad (reviewed in ref. 84). The newly formed PGCs
will differentiate into sperm or egg depending on the zygote’s sex,
and participate in the formation of the next generation.

9

Approaches for Manipulating Gene Expression in the Ovary
One of the biggest strengths of D. melanogaster as a model system
is its variety of advanced genetic tools. Below, we review a few of
the most widely used tools for studying gene function and development in the ovary.

9.1 The Use
of P elements
for Mutagenesis
and Gene Transfer
in Drosophila

Forward genetic screens often involve the use of chemical agents
or transposons to induce mutations in DNA sequence, which are
then analyzed for their phenotypic effects on the organism. In D.
melanogaster, the most popular chemical mutagen has been ethyl
methanesulfonate (EMS), due to its ease of use and efficient induction
of random point mutations (reviewed in ref. 89). An alternative to
chemical mutagenesis is the use of mobile genetic elements (transposons) to transpose to new genomic locations and in the process
disrupt gene function (reviewed in ref. 90). While many transposons exist in flies, the most commonly used has been the P element.
A wild-type P element consists of a pair of terminal inverted repeats
flanking the P transposase coding sequence, both of which are
necessary for transposition. DNA sequences of interest can be
placed between the P element inverted repeats and transformed
into random locations in the fly genome; removing the transposase
component, and instead supplying it in trans on a donor plasmid,
allows control of the P element’s mobilization [90]. Since the first
use of P elements for gene transfer in the early 1980s [91, 92], this
transposon has become the main workhorse of D. melanogaster
genetic engineering.

9.2 The
Gal4-UAS System

One of the more versatile and widely used genetic tools available in
D. melanogaster is the Gal4-UAS system. This two-component system for inducible activation of gene expression originated in yeast,
and was subsequently adapted to drive tissue-specific gene expression in flies [93]. The operating principle of this system is simple
and consists of two parts: (1) the transcriptional activator protein
Gal4, which selectively binds (2) upstream activation sequences
(UAS) in DNA, thereby activating transcription of a downstream
gene. The system as used in flies consists of a “driver” line, expressing a Gal4-encoding transgene under the control of tissue-specific
promoter or enhancer elements, and a Gal4-responsive “UAS” line
containing a gene of interest downstream of five or more tandem
UAS sites (Fig. 3a). A simple genetic cross of these two lines will

9.2.1 General Principle
of Operation
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Fig. 3 The Gal4-UAS and Flp-FRT systems: Principles of operation. (a) A female fly bearing a transgene under
UAS control is crossed to a male fly containing a Gal4 transgene under the control of a tissue-specific promoter
(in this example, a maternal promoter expressing at all stages of oogenesis). The progeny of the cross displays
ovary-specific expression of the transgene, indicated by the orange signal. (b) Use of the Flp-FRT recombination
system for creating homozygous mutant clones in the ovary. An original heterozygous mutant cell in G2 phase
is shown. The induction of Flp recombinase activates recombination between homologous FRT sites of nonsister chromatids. Following mitosis and cell division, one daughter cell is homozygous for the mutation of
interest (red asterisk) while the other daughter cell is homozygous WT (GFP). (c) Examples of germline (top)
and follicle cell (bottom) clones in the ovary. The presence of a homozygous mutant clone [white asterisk (top);
white broken line (bottom)] is indicated by loss of the GFP signal. Scale bar is 25 μm
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yield progeny with the desired tissue-specific expression pattern of
the gene of interest (reviewed in ref. 94).
The modular nature of this system, with each transgene carried
in a separate fly line, has many advantages. The specific requirement of Gal4 protein for UAS activation means that UAStransgenes encoding toxic or lethal gene products can be stably
maintained in a fly stock without deleterious effects. In addition, a
single Gal4 driver line can be mated with thousands of different
UAS lines, and vice versa, to achieve a huge variety of spatio-temporal
gene expression patterns [94]. Genes that can be placed under
UAS control include fluorescently tagged proteins, doublestranded RNA, or site-specific recombinases (e.g., FLPase and
Cre). Currently, there are thousands of Gal4 “driver” lines that
have been generated [95–98]. Their level of tissue specificity ranges
from ubiquitous expression (e.g., through the use of Ub or Act5C
promoters) to expression in one or a few cells (e.g., used in the
central nervous system), depending on the choice of promoter or
regulatory elements. Many of these lines, both Gal4 and UAS, are
publically available from Drosophila stock centers [99–101].
9.2.2 Germline-Specific
Caveats of the
Gal4-UAS System

Although its general principle of operation applies across all tissues,
attention should be paid to a few specific details when using Gal4UAS in the female germ line. The ability of Gal4-UAS to function
in the germ line is a more recent improvement, following the discovery that the basal promoter, terminator, and 3′ UTR sequences
of the UAS construct were critical for its proper expression [102].
The UAS vector modified for female germline expression, containing the P transposase promoter, K10 terminator, and 3′ UTR
sequence, was named “UASp” [ 102 ]. This is in contrast to
the standard “UAST” vector that is most commonly used for
expression in somatic tissues. An extensive list of characterized
Gal4 drivers for use in the female germ line has been recently
assembled [103].

9.2.3 Gal4-Inducible RNA
Interference (RNAi)

One of the more recently developed and powerful applications of
Gal4-UAS is the inducible, tissue-specific activation of RNAi for
knockdown of specific mRNA transcripts. This technology is especially useful for the study of genes that are highly pleiotropic or
lacking in classical mutant alleles. Two popular consortiums that
have designed and stock RNAi lines are the Drosophila Transgenic
RNAi Project (TRiP) [104] and the Vienna Drosophila RNAi
Center (VDRC) [100]. While the TRiP has exclusively used a
site-specific insertion strategy, via the ΦC31 integrase system, to
generate its inducible RNAi lines [105], the VDRC carries both
P element and ΦC31-mediated insertions [106]. The TRiP has
created a few “generations” of vectors containing inducible
RNAi transgenes. The most notable difference between these
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vectors is their level of expression in somatic versus germline tissues.
Therefore, the details of each type of vector must be examined
carefully before choosing a fly line for a particular experiment;
descriptions of each vector and its components are listed on the
TRiP’s web page [104].
The large number of existing transgenic RNAi stocks has
provided a platform for high-throughput loss of function screens
in ovaries and other tissues [107–109]. Inducible RNAi is now a
commonly used tool for studying gene function and development in D. melanogaster ovaries [110–112]. In principle, a specific mRNA transcript can be knocked down in any tissue(s) for
which there is an appropriate Gal4 line. A myriad of additional
applications of Gal4-UAS has been devised by using different
combinations of recombinases and fluorescent markers ([113]
and reviewed in ref. 114).
9.3 Mosaic Analysis
Using the Flp-FRT
System

Mosaic analysis is an extremely valuable tool for studying gene
function in a developing organism; it allows the production of
homozygous mutant cells in a heterozygous mutant animal [115].
Traditionally, the use of mosaic analysis in D. melanogaster was a
laborious and inefficient process. Ionizing radiation could be used
to induce mitotic recombination between non-sister chromatids
[116]; however, the efficiency of this process was very low (~1 %),
the recombination events occurred at random locations, and the
high levels of radiation often caused tissue damage to the fly. The
later incorporation of a yeast site-specific recombination system,
FLPase (Flp) and its FRT target sites (FLPase recombination targets), allowed the restriction of mitotic recombination to a single,
known chromosome arm and greatly increased its efficiency [117].
Performing mosaic analysis with the Flp-FRT system typically
involves crossing a mutation of interest, carried on an FRT chromosome, in trans to a homologous FRT chromosome bearing a
fluorescent or histological marker (e.g., GFP or LacZ, respectively)
(Fig. 3b). On a separate chromosome, either Gal4, a heat-shock
promoter, or a tissue-specific promoter can drive the expression of
Flp. In the progeny of this cross, mitotic recombination will occur
between the two FRT sites; clones that are homozygous for the
mutation of interest will be produced, and can be identified by
their lack of visual marker. In the context of a specific tissue, the
homozygous mutant clones will be surrounded by cells that are
either WT homozygous (also descended from mitotically recombined cells) or heterozygous (Fig. 3c).
As egg chambers are multicellular structures containing a
shared cytoplasm, a distinction must be made between transient
and stem cell derived clones. Transient clones are produced when
a mitotic recombination event takes place within the germline cyst
after the first cystoblast division. In this case, the population of
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nurse cells within one egg chamber will contain a mixture of genotypes: homozygous WT, homozygous mutant, and heterozygous.
The visual marker protein, along with other gene products, can
diffuse freely through ring canals and confound one’s ability to
unambiguously determine the genotype of each nurse cell.
Therefore only egg chambers that completely lack the visual marker
in each germline cell, indicating that they are derived from a GSC
recombination event, would be examined. Similarly, stem cell
derived and transient clones can be generated in the FCs, which
also contain ring canals that bridge small clusters of cells [118].
9.4 The Dominant
Female-Sterile Method
for Generating
Germline Mosaics

One alternative version of germline mosaic analysis is the dominant
female-sterile (DFS) technique: Instead of using visual markers to
identify clonal cell populations carrying a mutation of interest, a
dominant female-sterile allele is used to block the development of
non-homozygous mutant egg chambers. There are several dominant female-sterile alleles available, yet the most commonly used is
ovoD1 [119, 120]. The purpose of this technique is to exclusively
permit the formation of egg chambers that are homozygous for
the mutation of interest (i.e., cells that have lost ovoD1); egg chambers carrying cells that are heterozygous or homozygous for the
ovoD1 allele degenerate early in development.
The ovoD1 allele was originally recovered on the X chromosome,
and therefore the early use of this technique was limited to studying X-linked mutations. However, by engineering this allele into
P element vectors and creating transformants on additional chromosomes, this system was later expanded to include analysis of
autosomal mutations [121]. The main benefit of the DFS method,
as opposed to using the fluorescent or histological markers
described above, is for obtaining a uniform population of embryos
that are maternally homozygous for a mutation of interest. In this
way, the putative maternal effects of a gene can be analyzed by
genetic or biochemical methods.

9.5 Emerging
Technologies
for Genome
Engineering:
The CRISPR/Cas
System

A recent development in genome engineering technology, which
has gained popularity in Drosophila and other model organisms,
is CRISPR, for “Clustered Regularly Interspaced Palindromic
Repeats”. These genomic repeats are the basis of a bacterial and
archaeal RNA-based immune system through which organisms
acquire the ability to recognize invading genomic material [122].
Adaptive immunity is built over time by incorporating small DNA
repeats, captured from viral genomes or plasmids, into these specialized genomic clusters. CRISPR-associated (Cas) proteins, in
complex with small guide RNAs transcribed from these clusters,
are guided to homologous sequences to create double-stranded
DNA (dsDNA) breaks. There are three known types of CRISPR
systems, with the best characterized being Type II; these systems,
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as well as the mechanistic details of CRISPR repeat acquisition
and function, have been characterized (reviewed in refs. 122,
123).
CRISPR’s great value as a genome-engineering tool is its
ability to generate dsDNA breaks at specific genomic locations in
a variety of model systems [124]. These breaks then serve as an
entry point for different genome modification protocols (nonhomologous end joining, gene targeting with a dsDNA donor
template, etc.). A template encoding a chimeric RNA (chiRNA),
which combines the function of both guide and trans-activating
CRISPR RNA (tracrRNA), is designed to target a specific DNA
sequence. The chiRNA and Cas-expressing vectors are co-transfected or transformed, depending on the model system; the
expression of both transgenes results in targeting of the desired
DNA sequence (reviewed in ref. 125). The use of sequence-specific
DNA breaks greatly improves the efficiency of knockout creation
in mammalian cell culture, and organisms such as mice and flies.
More recent technical improvements in the efficiency and specificity of guide RNA targeting have been applied in D. melanogaster
(reviewed in ref. 126). This system is gaining popularity as a
method for creating transgenic flies, with gene knockout lines
having been generated using both non-homologous end joining
(NHEJ) and homology-directed repair with a dsDNA donor
template [127, 128]. One additional technical advance has been
the creation of transgenic lines stably expressing germline-driven
Cas9, dramatically increasing the efficiency of germline CRISPR
targeting [128, 129]. Some of these lines are available from the
Bloomington Drosophila Stock Center [99]. More information
on the CRISPR system is available online, including the “CRISPR
design tool” (based on [130]), discussion forum, FAQ, and troubleshooting [131].
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Conclusion
Drosophila melanogaster oogenesis continues to serve as an important model system for understanding fundamental aspects of cell
biology and development; in addition to its large variety of biological topics being actively investigated, it remains at the cutting edge
of technological innovation. Techniques such as live imaging of
cell migration, high-resolution light and electron microscopic
imaging of mRNA trafficking, and genetic/genomic manipulations with site-specific recombinases and transgenic RNAi have all
been applied, increasing the depth of our biological knowledge.
Moving forward, the study of the Drosophila ovary is poised to
further advance our understanding of basic mechanisms in eukaryotic biology.
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